BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-sandberg A, Domellof L. Pancreatitis and the Risk of Pancreatic Cancer. N Engl J Med 1993;328:1433-7. [DOI: 10.1056/nejm199305203282001] [Cited by in Crossref: 1159] [Cited by in F6Publishing: 1013] [Article Influence: 40.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu X, Xu X, Xiang Y, Fan D, An Q, Yue G, Jin Z, Ding J, Hu Y, Du Q, Xu J, Xie R. Exosome-mediated effects and applications in inflammatory diseases of the digestive system. Eur J Med Res 2022;27:163. [PMID: 36045437 DOI: 10.1186/s40001-022-00792-y] [Reference Citation Analysis]
2 Han SY, Conwell DL, Diaz PT, Ferketich A, Jeon CY, Yadav D, Hart PA. The deleterious effects of smoking on the development and progression of chronic pancreatitis. Pancreatology 2022:S1424-3903(22)00474-4. [PMID: 35981948 DOI: 10.1016/j.pan.2022.08.003] [Reference Citation Analysis]
3 Yang JM, Yang XY, Wan JH. Multiple roles for cholinergic signaling in pancreatic diseases. World J Gastroenterol 2022; 28(25): 2910-2919 [DOI: 10.3748/wjg.v28.i25.2910] [Reference Citation Analysis]
4 Seufferlein T, Mayerle J, Böck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL. Z Gastroenterol 2022;60:991-1037. [PMID: 35671996 DOI: 10.1055/a-1771-6811] [Reference Citation Analysis]
5 Farr KP, Moses D, Haghighi KS, Phillips PA, Hillenbrand CM, Chua BH. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Cancers 2022;14:2539. [DOI: 10.3390/cancers14102539] [Reference Citation Analysis]
6 Han L, Zhao Z, Yang K, Xin M, Zhou L, Chen S, Zhou S, Tang Z, Ji H, Dai R. Application of exosomes in the diagnosis and treatment of pancreatic diseases. Stem Cell Res Ther 2022;13:153. [PMID: 35395948 DOI: 10.1186/s13287-022-02826-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Han M, Tran TPT, Oh JK. Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea. Sci Rep 2022;12:5545. [PMID: 35365692 DOI: 10.1038/s41598-022-09426-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zakaria A, Al-Share B, Klapman JB, Dam A. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers (Basel) 2022;14:1373. [PMID: 35326524 DOI: 10.3390/cancers14061373] [Reference Citation Analysis]
9 Tong T, Gu J, Xu D, Song L, Zhao Q, Cheng F, Yuan Z, Tian S, Yang X, Tian J, Wang K, Jiang T. Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis. BMC Med 2022;20:74. [PMID: 35232446 DOI: 10.1186/s12916-022-02258-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Winter K, Dzieniecka M, Strzelczyk J, Wągrowska-Danilewicz M, Danilewicz M, Zatorski H, Małecka-Wojciesko E. Hedgehog Signaling Pathway Proteins in Prognosis of Pancreatic Ductal Adenocarcinoma and Its Differentiation From Chronic Pancreatitis. Pancreas 2022;51:219-27. [PMID: 35584378 DOI: 10.1097/MPA.0000000000002001] [Reference Citation Analysis]
11 Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI, Fishman DS, Golan T, Hidalgo M, Kwon RS, Riegert-Johnson DL, Sahani DV, Stoffel EM, Vollmer CM Jr, Qumseya BJ; ASGE STANDARDS OF PRACTICE COMMITTEE. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 2022:S0016-5107(21)01871-X. [PMID: 35183358 DOI: 10.1016/j.gie.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Jee KN. Metachronous occurrence of main-duct intraductal papillary mucinous neoplasm (IPMN) and adenocarcinoma in a chronic pancreatitis patient: A case report. Medicine (Baltimore) 2022;101:e28770. [PMID: 35147102 DOI: 10.1097/MD.0000000000028770] [Reference Citation Analysis]
13 Nissinen SI, Venäläinen M, Kumpulainen P, Roine A, Häkkinen MR, Vepsäläinen J, Oksala N, Rantanen T. Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel. Cancer Control 2021;28:10732748211039762. [PMID: 35135363 DOI: 10.1177/10732748211039762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Lee HA, Chen KW, Hsu CY. Prediction Model for Pancreatic Cancer-A Population-Based Study from NHIRD. Cancers (Basel) 2022;14:882. [PMID: 35205630 DOI: 10.3390/cancers14040882] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Khoury T, Sbeit W. Fatty Pancreas and Pancreatic Cancer: An Overlooked Association? JCM 2022;11:763. [DOI: 10.3390/jcm11030763] [Reference Citation Analysis]
16 Zou WB, Cooper DN, Masson E, Pu N, Liao Z, Férec C, Chen JM. Trypsinogen (PRSS1 and PRSS2) gene dosage correlates with pancreatitis risk across genetic and transgenic studies: a systematic review and re-analysis. Hum Genet 2022. [PMID: 35089416 DOI: 10.1007/s00439-022-02436-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
17 Korpela T, Ristimäki A, Udd M, Vuorela T, Mustonen H, Haglund C, Kylänpää L, Seppänen H. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma. BMC Cancer 2022;22:23. [PMID: 34980011 DOI: 10.1186/s12885-021-09080-0] [Reference Citation Analysis]
18 Martínez-Bosch N, Cristóbal H, Iglesias M, Gironella M, Barranco L, Visa L, Calafato D, Jiménez-Parrado S, Earl J, Carrato A, Manero-Rupérez N, Moreno M, Morales A, Guerra C, Navarro P, García de Frutos P. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. EBioMedicine 2022;75:103797. [PMID: 34973624 DOI: 10.1016/j.ebiom.2021.103797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Alhobayb T, Peravali R, Ashkar M. The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review. Diseases 2021;9:93. [PMID: 34940031 DOI: 10.3390/diseases9040093] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Cao D, Song Q, Li J, Jiang Y, Wang Z, Lu S. Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer. Expert Rev Mol Med 2021;23:e21. [PMID: 34906271 DOI: 10.1017/erm.2021.26] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
21 Winter K, Dzieniecka M, Strzelczyk J, Wągrowska-Danilewicz M, Danilewicz M, Małecka-Wojciesko E. Alpha Smooth Muscle Actin (αSMA) Immunohistochemistry Use in the Differentiation of Pancreatic Cancer from Chronic Pancreatitis. J Clin Med 2021;10:5804. [PMID: 34945100 DOI: 10.3390/jcm10245804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Dudley B, Brand RE. Pancreatic Cancer Surveillance and Novel Strategies for Screening. Gastrointest Endosc Clin N Am 2022;32:13-25. [PMID: 34798981 DOI: 10.1016/j.giec.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Cowan RW, Pratt ED, Kang JM, Zhao J, Wilhelm JJ, Abdulla M, Qiao EM, Brennan LP, Ulintz PJ, Bellin MD, Rhim AD. Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis. Clin Transl Gastroenterol 2021;12:e00431. [PMID: 34797250 DOI: 10.14309/ctg.0000000000000431] [Reference Citation Analysis]
24 Xu Y, Wang Y, Höti N, Clark DJ, Chen SY, Zhang H. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection. Mass Spectrom Rev 2021;:e21748. [PMID: 34766650 DOI: 10.1002/mas.21748] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Qian J, Tao D, Shan X, Xiao X, Chen C. Role of angiogenesis in beta-cell epithelial-mesenchymal transition in chronic pancreatitis-induced diabetes. Lab Invest 2021. [PMID: 34764436 DOI: 10.1038/s41374-021-00684-5] [Reference Citation Analysis]
26 Tao Y, Shao F, Cai M, Liu Z, Peng Y, Huang Q, Meng F. Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis. Front Oncol 2021;11:714598. [PMID: 34540683 DOI: 10.3389/fonc.2021.714598] [Reference Citation Analysis]
27 Ali H, Pamarthy R, Vallabhaneni M, Sarfraz S, Ali H, Rafique H. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database. F1000Res 2021;10:529. [PMID: 34527218 DOI: 10.12688/f1000research.54390.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
29 Dennaoui R, Shrestha H, Wagner KU. Models of pancreatic ductal adenocarcinoma. Cancer Metastasis Rev 2021;40:803-18. [PMID: 34491463 DOI: 10.1007/s10555-021-09989-9] [Reference Citation Analysis]
30 Sekine M, Tanaka A, Akimoto M, Miura T, Fujiwara J, Noda H, Rikiyama T, Ohnishi H, Mashima H. A Comparative Study of Endoscopic Ultrasonography and Histopathology Images for the Diagnosis of Early Chronic Pancreatitis. Pancreas 2021;50:1173-9. [PMID: 34714281 DOI: 10.1097/MPA.0000000000001893] [Reference Citation Analysis]
31 Diaconescu S, Gîlcă-Blanariu GE, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G. Could the burden of pancreatic cancer originate in childhood? World J Gastroenterol 2021; 27(32): 5322-5340 [PMID: 34539135 DOI: 10.3748/wjg.v27.i32.5322] [Reference Citation Analysis]
32 Luchini C, Fassan M, Doglioni C, Capelli P, Ingravallo G, Renzulli G, Pecori S, Paolino G, Florena AM, Scarpa A, Zamboni G. Inflammatory and tumor-like lesions of the pancreas. Pathologica 2020;112:197-209. [PMID: 33179622 DOI: 10.32074/1591-951X-168] [Reference Citation Analysis]
33 Chen X, Zeh HJ, Kang R, Kroemer G, Tang D. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34331036 DOI: 10.1038/s41575-021-00486-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 24.0] [Reference Citation Analysis]
34 Abdul Rahman R, Lamarca A, Hubner RA, Valle JW, McNamara MG. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer. Cancers (Basel) 2021;13:3779. [PMID: 34359684 DOI: 10.3390/cancers13153779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
35 Poddighe D. Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations. World J Gastroenterol 2021; 27(25): 3825-3836 [PMID: 34321847 DOI: 10.3748/wjg.v27.i25.3825] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tarasiuk A, Mackiewicz T, Małecka-Panas E, Fichna J. Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool? Cancer Biol Ther 2021;22:347-56. [PMID: 34224317 DOI: 10.1080/15384047.2021.1941584] [Reference Citation Analysis]
37 Tamura T, Kodama T, Sato K, Murai K, Yoshioka T, Shigekawa M, Yamada R, Hikita H, Sakamori R, Akita H, Eguchi H, Johnson RL, Yokoi H, Mukoyama M, Tatsumi T, Takehara T. Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation. J Clin Invest 2021;131:143414. [PMID: 34032634 DOI: 10.1172/JCI143414] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
38 Umans DS, Hoogenboom SA, Sissingh NJ, Lekkerkerker SJ, Verdonk RC, van Hooft JE. Pancreatitis and pancreatic cancer: A case of the chicken or the egg. World J Gastroenterol 2021; 27(23): 3148-3157 [PMID: 34163103 DOI: 10.3748/wjg.v27.i23.3148] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Tang L, Tang B, Lei Y, Yang M, Wang S, Hu S, Xie Z, Liu Y, Vlodavsky I, Yang S. Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis. Front Immunol 2021;12:675747. [PMID: 34220822 DOI: 10.3389/fimmu.2021.675747] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
40 Singhi AD, Wood LD. Early detection of pancreatic cancer using DNA-based molecular approaches. Nat Rev Gastroenterol Hepatol 2021;18:457-68. [PMID: 34099908 DOI: 10.1038/s41575-021-00470-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
41 Al-Fatlawi A, Malekian N, García S, Henschel A, Kim I, Dahl A, Jahnke B, Bailey P, Bolz SN, Poetsch AR, Mahler S, Grützmann R, Pilarsky C, Schroeder M. Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants. Cancers (Basel) 2021;13:2654. [PMID: 34071263 DOI: 10.3390/cancers13112654] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Zhang Y, Yang B, Davis JM, Drake MM, Younes M, Shen Q, Zhao Z, Cao Y, Ko TC. Distinct Murine Pancreatic Transcriptomic Signatures during Chronic Pancreatitis Recovery. Mediators Inflamm 2021;2021:5595464. [PMID: 34104113 DOI: 10.1155/2021/5595464] [Reference Citation Analysis]
43 Jiang W, Chen C, Huang L, Shen J, Yang L. GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression. Front Cell Dev Biol 2021;9:640391. [PMID: 33996796 DOI: 10.3389/fcell.2021.640391] [Reference Citation Analysis]
44 Monroy-Iglesias MJ, Dolly S, Sarker D, Thillai K, Van Hemelrijck M, Santaolalla A. Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies. J Clin Med 2021;10:1665. [PMID: 33924591 DOI: 10.3390/jcm10081665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Ungefroren H, Christl J, Eiden C, Wellner UF, Lehnert H, Marquardt JU. Autocrine TGFβ1 Opposes Exogenous TGFβ1-Induced Cell Migration and Growth Arrest through Sustainment of a Feed-Forward Loop Involving MEK-ERK Signaling. Cancers (Basel) 2021;13:1357. [PMID: 33802809 DOI: 10.3390/cancers13061357] [Reference Citation Analysis]
46 Edelman HE, McClymont SA, Tucker TR, Pineda S, Beer RL, McCallion AS, Parsons MJ. SOX9 modulates cancer biomarker and cilia genes in pancreatic cancer. Hum Mol Genet 2021;30:485-99. [PMID: 33693707 DOI: 10.1093/hmg/ddab064] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Maatman TK, Zyromski NJ. In Brief. Current Problems in Surgery 2021;58:100859. [DOI: 10.1016/j.cpsurg.2020.100859] [Reference Citation Analysis]
48 Anand U, Khandelwal C, Senthilnathan P, Sabnis SC, Palanivelu C, Kumar B, Kumar R, Priyadarshi RN, Parasar K. The Current Concepts and Management of Idiopathic (Tropical) Chronic Pancreatitis. Indian J Surg 2021;83:828-35. [DOI: 10.1007/s12262-021-02780-8] [Reference Citation Analysis]
49 Bastian P, Dulski J, Roszmann A, Jacewicz D, Kuban-Jankowska A, Slawek J, Wozniak M, Gorska-Ponikowska M. Regulation of Mitochondrial Dynamics in Parkinson's Disease-Is 2-Methoxyestradiol a Missing Piece? Antioxidants (Basel) 2021;10:248. [PMID: 33562035 DOI: 10.3390/antiox10020248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Leal AS, Liu P, Krieger-Burke T, Ruggeri B, Liby KT. The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Cancers (Basel) 2020;13:E96. [PMID: 33396954 DOI: 10.3390/cancers13010096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ciernikova S, Novisedlakova M, Cholujova D, Stevurkova V, Mego M. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.Biomedicines. 2020;8. [PMID: 33287196 DOI: 10.3390/biomedicines8120565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
52 Lu W, Li X, Luo Y. FGF21 in obesity and cancer: New insights. Cancer Lett 2021;499:5-13. [PMID: 33264641 DOI: 10.1016/j.canlet.2020.11.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
53 Das Mahapatra A, Choubey R, Datta B. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer. Molecules 2020;25:E5488. [PMID: 33255197 DOI: 10.3390/molecules25235488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
54 Vujasinovic M, Dugic A, Maisonneuve P, Aljic A, Berggren R, Panic N, Valente R, Pozzi Mucelli R, Waldthaler A, Ghorbani P, Kordes M, Hagström H, Löhr JM. Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis. J Clin Med 2020;9:E3720. [PMID: 33228173 DOI: 10.3390/jcm9113720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
55 Garcia PE, Scales MK, Allen BL, Pasca di Magliano M. Pancreatic Fibroblast Heterogeneity: From Development to Cancer. Cells 2020;9:E2464. [PMID: 33198201 DOI: 10.3390/cells9112464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
56 Matsubayashi H, Ishiwatari H, Sasaki K, Uesaka K, Ono H. Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut Liver. 2020;14:30-36. [PMID: 31009958 DOI: 10.5009/gnl18491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
57 Schnipper J, Dhennin-Duthille I, Ahidouch A, Ouadid-Ahidouch H. Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma. Front Pharmacol 2020;11:568993. [PMID: 33178018 DOI: 10.3389/fphar.2020.568993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
58 Khurana N, Dodhiawala PB, Bulle A, Lim KH. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer. Cancers (Basel) 2020;12:E2675. [PMID: 32961746 DOI: 10.3390/cancers12092675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
59 Liu QY, Abu-El-Haija M, Husain SZ, Barth B, Bellin M, Fishman DS, Freedman SD, Gariepy CE, Giefer MJ, Gonska T, Heyman MB, Himes R, Lin TK, Maqbool A, Mascarenhas M, McFerron BA, Morinville VD, Nathan JD, Ooi CY, Perito ER, Pohl JF, Rhee S, Schwarzenberg SJ, Shah U, Troendle D, Werlin SL, Wilschanski M, Zimmerman MB, Lowe ME, Uc A. Risk Factors for Rapid Progression From Acute Recurrent to Chronic Pancreatitis in Children: Report From INSPPIRE. J Pediatr Gastroenterol Nutr 2019;69:206-11. [PMID: 31136562 DOI: 10.1097/MPG.0000000000002405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
60 Lee JE, Cho SG, Ko SG, Ahrmad SA, Puga A, Kim K. Regulation of a long noncoding RNA MALAT1 by aryl hydrocarbon receptor in pancreatic cancer cells and tissues. Biochem Biophys Res Commun 2020;532:563-9. [PMID: 32900487 DOI: 10.1016/j.bbrc.2020.08.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Sun W, Ren Y, Lu Z, Zhao X. The potential roles of exosomes in pancreatic cancer initiation and metastasis. Mol Cancer 2020;19:135. [PMID: 32878635 DOI: 10.1186/s12943-020-01255-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
62 Singhvi A, Abromitis R, Althouse AD, Bataller R, Arteel GE, Yadav D. Coexistence of alcohol-related pancreatitis and alcohol-related liver disease: A systematic review and meta-analysis. Pancreatology 2020;20:1069-77. [PMID: 32800649 DOI: 10.1016/j.pan.2020.07.412] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Bangs FK, Miller P, O'Neill E. Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse. Dis Model Mech 2020;13:dmm044289. [PMID: 32571902 DOI: 10.1242/dmm.044289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Cancer Imaging 2020;20:52. [PMID: 32703312 DOI: 10.1186/s40644-020-00324-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
65 Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD, Thomas CR Jr. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin 2020;70:375-403. [PMID: 32683683 DOI: 10.3322/caac.21626] [Cited by in Crossref: 25] [Cited by in F6Publishing: 83] [Article Influence: 12.5] [Reference Citation Analysis]
66 Perkail S, Andricovich J, Kai Y, Tzatsos A. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun 2020;11:3018. [PMID: 32541668 DOI: 10.1038/s41467-020-16589-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
67 Weng W, Zhang Z, Huang W, Xu X, Wu B, Ye T, Shan Y, Shi K, Lin Z. Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma. Cancer Cell Int 2020;20:231. [PMID: 32536819 DOI: 10.1186/s12935-020-01243-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
68 Macias RIR, Muñoz-Bellvís L, Sánchez-Martín A, Arretxe E, Martínez-Arranz I, Lapitz A, Gutiérrez ML, La Casta A, Alonso C, González LM, Avila MA, Martinez-Chantar ML, Castro RE, Bujanda L, Banales JM, Marin JJG. A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 2020;12:E1433. [PMID: 32486461 DOI: 10.3390/cancers12061433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
69 Davis JM, Cheng B, Drake MM, Yu Q, Yang B, Li J, Liu C, Younes M, Zhao X, Bailey JM, Shen Q, Ko TC, Cao Y. Pancreatic stromal Gremlin 1 expression during pancreatic tumorigenesis. Genes Dis 2022;9:108-15. [PMID: 35005111 DOI: 10.1016/j.gendis.2020.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Elsalem L, Jum'ah AA, Alfaqih MA, Aloudat O. The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives. Clin Exp Gastroenterol 2020;13:151-85. [PMID: 32440192 DOI: 10.2147/CEG.S243337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
71 Shanbhogue KP, Pourvaziri A, Jeyaraj SK, Kambadakone A. Endoscopic and surgical treatment options for chronic pancreatitis: an imaging perspective. Abdom Radiol (NY) 2020;45:1397-409. [PMID: 31707437 DOI: 10.1007/s00261-019-02249-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Engle DD, Tiriac H, Rivera KD, Pommier A, Whalen S, Oni TE, Alagesan B, Lee EJ, Yao MA, Lucito MS, Spielman B, Da Silva B, Schoepfer C, Wright K, Creighton B, Afinowicz L, Yu KH, Grützmann R, Aust D, Gimotty PA, Pollard KS, Hruban RH, Goggins MG, Pilarsky C, Park Y, Pappin DJ, Hollingsworth MA, Tuveson DA. The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science 2019;364:1156-62. [PMID: 31221853 DOI: 10.1126/science.aaw3145] [Cited by in Crossref: 70] [Cited by in F6Publishing: 89] [Article Influence: 35.0] [Reference Citation Analysis]
73 de Oliveira G, Freire PP, Cury SS, de Moraes D, Oliveira JS, Dal-Pai-Silva M, Reis PP, Carvalho RF. An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma. Cancers (Basel). 2020;12:716. [PMID: 32197468 DOI: 10.3390/cancers12030716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
74 Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, Murage E, Vykoukal J, Kundnani DL, Foretova L, Fabianova E, Holcatova I, Janout V, Feng Z, Yip-Schneider M, Zhang J, Brand R, Taguchi A, Maitra A, Brennan P, Max Schmidt C, Hanash S. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2019;111:372-379. [PMID: 30137376 DOI: 10.1093/jnci/djy126] [Cited by in Crossref: 40] [Cited by in F6Publishing: 54] [Article Influence: 20.0] [Reference Citation Analysis]
75 Matsubayashi H, Takaori K, Morizane C, Kiyozumi Y. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals. Gut Liver 2019;13:498-505. [PMID: 30917631 DOI: 10.5009/gnl18449] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
76 Llach J, Carballal S, Moreira L. Familial Pancreatic Cancer: Current Perspectives. Cancer Manag Res 2020;12:743-58. [PMID: 32099470 DOI: 10.2147/CMAR.S172421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
77 Gumpper K, Dangel AW, Pita-Grisanti V, Krishna SG, Lara LF, Mace T, Papachristou GI, Conwell DL, Hart PA, Cruz-Monserrate Z. Lipocalin-2 expression and function in pancreatic diseases. Pancreatology 2020;20:419-24. [PMID: 31932215 DOI: 10.1016/j.pan.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Singh VK, Yadav D, Garg PK. Diagnosis and Management of Chronic Pancreatitis: A Review. JAMA 2019;322:2422-34. [PMID: 31860051 DOI: 10.1001/jama.2019.19411] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 41.0] [Reference Citation Analysis]
79 Perusina Lanfranca M, Zhang Y, Girgis A, Kasselman S, Lazarus J, Kryczek I, Delrosario L, Rhim A, Koneva L, Sartor M, Sun L, Halbrook C, Nathan H, Shi J, Crawford HC, Pasca di Magliano M, Zou W, Frankel TL. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. Gastroenterology 2020;158:1417-1432.e11. [PMID: 31843590 DOI: 10.1053/j.gastro.2019.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
80 Rodrigues-Pinto E, Caldeira A, Soares JB, Antunes T, Carvalho JR, Costa-Maia J, Oliveira P, Azevedo R, Liberal R, Bouça Machado T, Magno-Pereira V, Moutinho-Ribeiro P. Clube Português do Pâncreas Recommendations for Chronic Pancreatitis: Medical, Endoscopic, and Surgical Treatment (Part II). GE Port J Gastroenterol 2019;26:404-13. [PMID: 31832495 DOI: 10.1159/000497389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
81 Lee KE, Spata M, Maduka R, Vonderheide RH, Simon MC. Hif1α Deletion Limits Tissue Regeneration via Aberrant B Cell Accumulation in Experimental Pancreatitis. Cell Rep 2018;23:3457-64. [PMID: 29924990 DOI: 10.1016/j.celrep.2018.05.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
82 Batista S, Gregório AC, Hanada Otake A, Couto N, Costa-Silva B. The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective. J Oncol 2019;2019:6240505. [PMID: 31885581 DOI: 10.1155/2019/6240505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
83 Matsubayashi H, Kiyozumi Y, Ishiwatari H, Uesaka K, Kikuyama M, Ono H. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Diagnostics (Basel) 2019;9:E169. [PMID: 31683730 DOI: 10.3390/diagnostics9040169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
84 Liu Q, Guo L, Zhang S, Wang J, Lin X, Gao F. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer. Mol Med 2019;25:44. [PMID: 31521106 DOI: 10.1186/s10020-019-0111-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
85 Shobassy M, Husainat N, Tabash A, Patel K, El-Serag HB, Othman MO. Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1. Gastroenterol Res Pract 2019;2019:5290642. [PMID: 31485218 DOI: 10.1155/2019/5290642] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
86 Choi JW, Lee SK, Kim MJ, Kim DG, Shin JY, Zhou Z, Jo IJ, Song HJ, Bae GS, Park SJ. Piperine ameliorates the severity of fibrosis via inhibition of TGF‑β/SMAD signaling in a mouse model of chronic pancreatitis. Mol Med Rep 2019;20:3709-18. [PMID: 31485676 DOI: 10.3892/mmr.2019.10635] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
87 Shen CN, Goh KS, Huang CR, Chiang TC, Lee CY, Jeng YM, Peng SJ, Chien HJ, Chung MH, Chou YH, Hsieh CC, Kulkarni S, Pasricha PJ, Tien YW, Tang SC. Lymphatic vessel remodeling and invasion in pancreatic cancer progression. EBioMedicine 2019;47:98-113. [PMID: 31495721 DOI: 10.1016/j.ebiom.2019.08.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
88 Krah NM, Narayanan SM, Yugawa DE, Straley JA, Wright CVE, MacDonald RJ, Murtaugh LC. Prevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism. Dev Cell 2019;50:744-754.e4. [PMID: 31422917 DOI: 10.1016/j.devcel.2019.07.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
89 Uslu HI, Dölle AR, Dullemen HM, Aktas H, Kolkman JJ, Venneman NG. Pancreatic ductal adenocarcinoma and chronic pancreatitis may be diagnosed by exhaled-breath profiles: a multicenter pilot study. Clin Exp Gastroenterol 2019;12:385-90. [PMID: 31616173 DOI: 10.2147/CEG.S189102] [Reference Citation Analysis]
90 Guo XY, Xiao F, Li J, Zhou YN, Zhang WJ, Sun B, Wang G. Exosomes and pancreatic diseases: status, challenges, and hopes. Int J Biol Sci 2019;15:1846-60. [PMID: 31523187 DOI: 10.7150/ijbs.35823] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
91 Gao C, Chen G, Zhang DH, Zhang J, Kuan SF, Hu W, Esni F, Gao X, Guan JL, Chu E, Hu J. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-CateninY654. Cell Mol Gastroenterol Hepatol 2019;8:561-78. [PMID: 31330317 DOI: 10.1016/j.jcmgh.2019.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
92 Zheng Z, Chen Y, Tan C, Ke N, Du B, Liu X. Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis. BMC Surg. 2019;19:83. [PMID: 31286902 DOI: 10.1186/s12893-019-0537-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
93 Righetti A, Giulietti M, Šabanović B, Occhipinti G, Principato G, Piva F. CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer? J Oncol 2019;2019:9681698. [PMID: 31275385 DOI: 10.1155/2019/9681698] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
94 Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 2019;18:97. [PMID: 31109338 DOI: 10.1186/s12943-019-1008-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 89] [Article Influence: 17.7] [Reference Citation Analysis]
95 Frola C, Somasundaram M, Hariharan D, Kolaityte V, Mohandas S, Stättner S, Yip VS. The role of surgery in chronic pancreatitis. Eur Surg 2019;51:114-20. [DOI: 10.1007/s10353-019-0591-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
96 Muhammad W, Hart GR, Nartowt B, Farrell JJ, Johung K, Liang Y, Deng J.   Pancreatic cancer prediction through an artificial neural network. Frontiers in Artificial Intelligence 2019; 2: 2. [PMID: 33733091 DOI: 10.3389/frai.2019.00002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
97 Ikuta K, Fukuda A, Ogawa S, Masuo K, Goto N, Hiramatsu Y, Tsuda M, Kimura Y, Matsumoto Y, Kimura Y, Maruno T, Kanda K, Nishi K, Takaori K, Uemoto S, Takaishi S, Chiba T, Nishi E, Seno H. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Gut 2019;68:882-92. [PMID: 29798841 DOI: 10.1136/gutjnl-2017-315425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Soufi M, Yip-Schneider MT, Carr RA, Roch AM, Wu HH, Schmidt CM. Multifocal High-Grade Pancreatic Precursor Lesions: A Case Series and Management Recommendations. J Pancreat Cancer 2019;5:8-11. [PMID: 31289790 DOI: 10.1089/pancan.2019.0001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Resovi A, Bani MR, Porcu L, Anastasia A, Minoli L, Allavena P, Cappello P, Novelli F, Scarpa A, Morandi E, Falanga A, Torri V, Taraboletti G, Belotti D, Giavazzi R. Soluble stroma-related biomarkers of pancreatic cancer. EMBO Mol Med 2018;10:e8741. [PMID: 29941541 DOI: 10.15252/emmm.201708741] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
100 Phillips AE, Shah N, Borhani AA, Yadav D, Brand RE. Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma. Pancreas. 2018;47:1262-1266. [PMID: 30286010 DOI: 10.1097/mpa.0000000000001160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
101 Winter K, Talar-Wojnarowska R, Dąbrowski A, Degowska M, Durlik M, Gąsiorowska A, Głuszek S, Jurkowska G, Kaczka A, Lampe P, Marek T, Nasierowska-Guttmejer A, Nowakowska-Duława E, Rydzewska G, Strzelczyk J, Śledziński Z, Małecka-Panas E. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Prz Gastroenterol 2019;14:1-18. [PMID: 30944673 DOI: 10.5114/pg.2019.83422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
102 Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10:10-27. [PMID: 30834048 DOI: 10.14740/wjon1166] [Cited by in Crossref: 473] [Cited by in F6Publishing: 737] [Article Influence: 157.7] [Reference Citation Analysis]
103 Cazacu IM, Farkas N, Garami A, Balaskó M, Mosdósi B, Alizadeh H, Gyöngyi Z, Rakonczay Z Jr, Vigh É, Habon T, Czopf L, Lazarescu MA, Erőss B, Sahin-Tóth M, Hegyi P. Pancreatitis-Associated Genes and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. Pancreas 2018;47:1078-86. [PMID: 30134356 DOI: 10.1097/MPA.0000000000001145] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
104 Zhan W, Shelton CA, Greer PJ, Brand RE, Whitcomb DC. Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts. Pancreas 2018;47:924-36. [PMID: 30113427 DOI: 10.1097/MPA.0000000000001136] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
105 Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer. 2019;18:14. [PMID: 30665410 DOI: 10.1186/s12943-018-0927-5] [Cited by in Crossref: 93] [Cited by in F6Publishing: 141] [Article Influence: 31.0] [Reference Citation Analysis]
106 Moin ASM, Cory M, Choi J, Ong A, Dhawan S, Dry SM, Butler PC, Rizza RA, Butler AE. Increased Chromogranin A-Positive Hormone-Negative Cells in Chronic Pancreatitis. J Clin Endocrinol Metab 2018;103:2126-35. [PMID: 29659906 DOI: 10.1210/jc.2017-01562] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
107 Xu YXZ, Mishra S. Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models. Cancers (Basel) 2018;10:E523. [PMID: 30567335 DOI: 10.3390/cancers10120523] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
108 Capasso M, Franceschi M, Rodriguez-Castro KI, Crafa P, Cambiè G, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Epidemiology and risk factors of pancreatic cancer. Acta Biomed 2018;89:141-6. [PMID: 30561407 DOI: 10.23750/abm.v89i9-S.7923] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
109 Means AL. ATRX Links Chromatin Remodeling to Inflammation and Tumorigenesis in the Pancreas. Cell Mol Gastroenterol Hepatol 2019;7:233-4. [PMID: 30539789 DOI: 10.1016/j.jcmgh.2018.10.001] [Reference Citation Analysis]
110 Lin YC, Kor CT, Su WW, Hsu YC. Risk factors and prediction score for chronic pancreatitis: A nationwide population-based cohort study. World J Gastroenterol 2018; 24(44): 5034-5045 [PMID: 30510378 DOI: 10.3748/wjg.v24.i44.5034] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
111 Zou WB, Tang XY, Zhou DZ, Qian YY, Hu LH, Yu FF, Yu D, Wu H, Deng SJ, Lin JH, Zhao AJ, Zhao ZH, Wu HY, Zhu JH, Qian W, Wang L, Xin L, Wang MJ, Wang LJ, Fang X, He L, Masson E, Cooper DN, Férec C, Li ZS, Chen JM, Liao Z. SPINK1, PRSS1, CTRC, and CFTR Genotypes Influence Disease Onset and Clinical Outcomes in Chronic Pancreatitis. Clin Transl Gastroenterol 2018;9:204. [PMID: 30420730 DOI: 10.1038/s41424-018-0069-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
112 Gromski MA, Lehman GA, Zyromski NJ, Watkins JL, El Hajj II, Tan D, McHenry L, Easler JJ, Tirkes T, Sherman S, Fogel EL. Annular pancreas: endoscopic and pancreatographic findings from a tertiary referral ERCP center. Gastrointest Endosc. 2019;89:322-328. [PMID: 30240880 DOI: 10.1016/j.gie.2018.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Kadaj-Lipka R, Lipiński M, Adrych K, Durlik M, Gąsiorowska A, Jarosz M, Jurkowska G, Małecka-Panas E, Oracz G, Rosołowski M, Skrzydło-Radomańska B, Talar-Wojnarowska R, Rydzewska G. Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club. Prz Gastroenterol 2018;13:167-81. [PMID: 30302160 DOI: 10.5114/pg.2018.78067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Ntala C, Debernardi S, Feakins RM, Crnogorac-Jurcevic T. Demographic, clinical, and pathological features of early onset pancreatic cancer patients. BMC Gastroenterol 2018;18:139. [PMID: 30208959 DOI: 10.1186/s12876-018-0866-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
115 Jalal M, Campbell JA, Hopper AD. Practical guide to the management of chronic pancreatitis. Frontline Gastroenterol 2019;10:253-60. [PMID: 31288255 DOI: 10.1136/flgastro-2018-101071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
116 Cullis J, Das S, Bar-Sagi D. Kras and Tumor Immunity: Friend or Foe? Cold Spring Harb Perspect Med. 2018;8. [PMID: 29229670 DOI: 10.1101/cshperspect.a031849] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
117 Martinez-Bosch N, Barranco LE, Orozco CA, Moreno M, Visa L, Iglesias M, Oldfield L, Neoptolemos JP, Greenhalf W, Earl J, Carrato A, Costello E, Navarro P. Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker. Oncotarget 2018;9:32984-96. [PMID: 30250644 DOI: 10.18632/oncotarget.26034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
118 Piktel E, Levental I, Durnaś B, Janmey PA, Bucki R. Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target. Int J Mol Sci 2018;19:E2516. [PMID: 30149613 DOI: 10.3390/ijms19092516] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 12.3] [Reference Citation Analysis]
119 Hu C, LaDuca H, Shimelis H, Polley EC, Lilyquist J, Hart SN, Na J, Thomas A, Lee KY, Davis BT, Black MH, Pesaran T, Goldgar DE, Dolinsky JS, Couch FJ. Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes. JCO Precis Oncol 2018;2. [PMID: 31497750 DOI: 10.1200/PO.17.00291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
120 Burclaff J, Mills JC. Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas. Dis Model Mech 2018;11:dmm033373. [PMID: 30037967 DOI: 10.1242/dmm.033373] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
121 Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K. In vivo reprogramming drives Kras-induced cancer development. Nat Commun. 2018;9:2081. [PMID: 29802314 DOI: 10.1038/s41467-018-04449-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
122 Makarova-Rusher OV, Ulahannan S, Greten TF, Duffy A. Pancreatic Squamous Cell Carcinoma: A Population-Based Study of Epidemiology, Clinicopathologic Characteristics and Outcomes. Pancreas 2016;45:1432-7. [PMID: 27214394 DOI: 10.1097/MPA.0000000000000658] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 7.8] [Reference Citation Analysis]
123 Handler J, Cullis J, Avanzi A, Vucic EA, Bar-Sagi D. Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure. Oncogene 2018;37:4334-42. [PMID: 29713060 DOI: 10.1038/s41388-018-0264-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
124 Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, Xiong Y, Merchant NB. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells. Oncotarget 2016;7:65982-92. [PMID: 27602757 DOI: 10.18632/oncotarget.11786] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
125 Wu L, Zheng W, Xiang YB, Gao YT, Li HL, Cai H, Shu XO. Physical Activity and Pancreatic Cancer Risk among Urban Chinese: Results from Two Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev 2018;27:479-87. [PMID: 29475964 DOI: 10.1158/1055-9965.EPI-17-0895] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
126 Uchida K, Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol. 2018;53:475-483. [PMID: 29460239 DOI: 10.1007/s00535-018-1440-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
127 Kikuyama M, Kamisawa T, Kuruma S, Chiba K, Kawaguchi S, Terada S, Satoh T. Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer. Cancers (Basel). 2018;10. [PMID: 29439461 DOI: 10.3390/cancers10020048] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
128 Fendrich V, Jendryschek F, Beeck S, Albers M, Lauth M, Esni F, Heeger K, Dengler J, Slater EP, Holler JPN, Baier A, Bartsch DK, Waldmann J. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury. Oncogene 2018;37:1845-56. [PMID: 29367759 DOI: 10.1038/s41388-017-0100-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
129 Krah NM, Murtaugh LC. Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis. Trends Cancer 2016;2:723-35. [PMID: 28630946 DOI: 10.1016/j.trecan.2016.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
130 Peng W, Furuuchi N, Aslanukova L, Huang YH, Brown SZ, Jiang W, Addya S, Vishwakarma V, Peters E, Brody JR, Dixon DA, Sawicki JA. Elevated HuR in Pancreas Promotes a Pancreatitis-Like Inflammatory Microenvironment That Facilitates Tumor Development. Mol Cell Biol 2018;38:e00427-17. [PMID: 29133460 DOI: 10.1128/MCB.00427-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
131 Mayerle J, Kalthoff H, Reszka R, Kamlage B, Peter E, Schniewind B, González Maldonado S, Pilarsky C, Heidecke CD, Schatz P, Distler M, Scheiber JA, Mahajan UM, Weiss FU, Grützmann R, Lerch MM. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 2018;67:128-37. [PMID: 28108468 DOI: 10.1136/gutjnl-2016-312432] [Cited by in Crossref: 128] [Cited by in F6Publishing: 126] [Article Influence: 32.0] [Reference Citation Analysis]
132 Kong B, Bruns P, Behler NA, Chang L, Schlitter AM, Cao J, Gewies A, Ruland J, Fritzsche S, Valkovskaya N, Jian Z, Regel I, Raulefs S, Irmler M, Beckers J, Friess H, Erkan M, Mueller NS, Roth S, Hackert T, Esposito I, Theis FJ, Kleeff J, Michalski CW. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut 2018;67:146-56. [PMID: 27646934 DOI: 10.1136/gutjnl-2015-310913] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
133 Hong X, Zhang J, Wu Q, Wang W, Ye AY, Song W, Dai H, Wang X, Wu F, You L. Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice. Oncotarget. 2016; Mar 17. [Epub ahead of print]. [PMID: 27009811 DOI: 10.18632/oncotarget.8148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
134 Principe DR, DeCant B, Diaz AM, Mangan RJ, Hwang R, Lowy A, Shetuni BB, Sreekumar BK, Chung C, Bentrem DJ, Munshi HG, Jung B, Grippo PJ, Bishehsari F. PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction. Oncotarget 2016;7:28218-34. [PMID: 27058416 DOI: 10.18632/oncotarget.8587] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
135 Le Magnen C, Shen MM, Abate-Shen C. Lineage Plasticity in Cancer Progression and Treatment. Annu Rev Cancer Biol 2018;2:271-89. [PMID: 29756093 DOI: 10.1146/annurev-cancerbio-030617-050224] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
136 Peng M, Zhang Q, Cheng Y, Fu S, Yang H, Guo X, Zhang J, Wang L, Zhang L, Xue Z, Li Y, Da Y, Yao Z, Qiao L, Zhang R. Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression. Oncotarget 2017;8:99693-706. [PMID: 29245934 DOI: 10.18632/oncotarget.21157] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
137 Kirkegård J, Mortensen FV, Cronin-fenton D. Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis. American Journal of Gastroenterology 2017;112:1366-72. [DOI: 10.1038/ajg.2017.218] [Cited by in Crossref: 141] [Cited by in F6Publishing: 177] [Article Influence: 28.2] [Reference Citation Analysis]
138 Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget 2017;8:16473-87. [PMID: 28146435 DOI: 10.18632/oncotarget.14869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
139 Xiao X, Fischbach S, Zhang T, Chen C, Sheng Q, Zimmerman R, Patnaik S, Fusco J, Ming Y, Guo P, Shiota C, Prasadan K, Gangopadhyay N, Husain SZ, Dong H, Gittes GK. SMAD3/Stat3 Signaling Mediates β-Cell Epithelial-Mesenchymal Transition in Chronic Pancreatitis-Related Diabetes. Diabetes 2017;66:2646-58. [PMID: 28775125 DOI: 10.2337/db17-0537] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
140 Lau SC, Cheung WY. Evolving treatment landscape for early and advanced pancreatic cancer. World J Gastrointest Oncol 2017; 9(7): 281-292 [PMID: 28808501 DOI: 10.4251/wjgo.v9.i7.281] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
141 Li M, Chen Q, Ma T, Yu X. Targeting reactive nitrogen species suppresses hereditary pancreatic cancer. Proc Natl Acad Sci U S A 2017;114:7106-11. [PMID: 28630313 DOI: 10.1073/pnas.1702156114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
142 Khalafalla FG, Khan MW. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents. Cancer Growth Metastasis. 2017;10:1179064417709287. [PMID: 28579826 DOI: 10.1177/1179064417709287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
143 Mohamadkhani A, Pourshams A, Viti J, Cellai F, Mortazavi K, Sharafkhah M, Sotoudeh M, Malekzadeh R, Boffetta P, Peluso M. Pancreatic Cancer is Associated with Peripheral Leukocyte Oxidative DNA Damage. Asian Pac J Cancer Prev 2017;18:1349-55. [PMID: 28612585 DOI: 10.22034/APJCP.2017.18.5.1349] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
144 Yamabe A, Irisawa A, Shibukawa G, Sato A, Fujisawa M, Arakawa N, Yoshida Y, Abe Y, Igarashi R, Maki T. Early diagnosis of chronic pancreatitis: understanding the factors associated with the development of chronic pancreatitis. Fukushima J Med Sci. 2017;63:1-7. [PMID: 28450665 DOI: 10.5387/fms.2016-14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
145 Daley D, Mani VR, Mohan N, Akkad N, Pandian GSDB, Savadkar S, Lee KB, Torres-Hernandez A, Aykut B, Diskin B. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724. [PMID: 28442553 DOI: 10.1084/jem.20161707] [Cited by in Crossref: 80] [Cited by in F6Publishing: 104] [Article Influence: 16.0] [Reference Citation Analysis]
146 Li S, Li R, Wang H, Li L, Li H, Li Y. The Key Genes of Chronic Pancreatitis which Bridge Chronic Pancreatitis and Pancreatic Cancer Can be Therapeutic Targets. Pathol Oncol Res 2018;24:215-22. [PMID: 28435988 DOI: 10.1007/s12253-017-0217-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
147 Macinga P, Pulkertova A, Bajer L, Maluskova J, Oliverius M, Smejkal M, Heczkova M, Spicak J, Hucl T. Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass. World J Gastroenterol 2017; 23(12): 2185-2193 [PMID: 28405146 DOI: 10.3748/wjg.v23.i12.2185] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
148 Ramsey ML, Conwell DL, Hart PA. Complications of Chronic Pancreatitis. Dig Dis Sci. 2017;62:1745-1750. [PMID: 28281169 DOI: 10.1007/s10620-017-4518-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 11.8] [Reference Citation Analysis]
149 Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J. Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med 2017;6:E29. [PMID: 28282928 DOI: 10.3390/jcm6030029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
150 Yamaguchi J, Yokoyama Y, Kokuryo T, Ebata T, Nagino M. Cells of origin of pancreatic neoplasms. Surg Today. 2018;48:9-17. [PMID: 28260136 DOI: 10.1007/s00595-017-1501-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
151 Sheth SG, Conwell DL, Whitcomb DC, Alsante M, Anderson MA, Barkin J, Brand R, Cote GA, Freedman SD, Gelrud A, Gorelick F, Lee LS, Morgan K, Pandol S, Singh VK, Yadav D, Wilcox CM, Hart PA. Academic Pancreas Centers of Excellence: Guidance from a multidisciplinary chronic pancreatitis working group at PancreasFest. Pancreatology. 2017;17:419-430. [PMID: 28268158 DOI: 10.1016/j.pan.2017.02.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
152 Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 Levels for diagnosing pancreatic cancer. Cancer Lett. 2017;393:86-93. [PMID: 28232049 DOI: 10.1016/j.canlet.2017.02.019] [Cited by in Crossref: 144] [Cited by in F6Publishing: 178] [Article Influence: 28.8] [Reference Citation Analysis]
153 Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Familial pancreatic cancer: Concept, management and issues. World J Gastroenterol 2017; 23(6): 935-948 [PMID: 28246467 DOI: 10.3748/wjg.v23.i6.935] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 46] [Article Influence: 11.4] [Reference Citation Analysis]
154 Zhang D, Lei J, Ma J, Chen X, Sheng L, Jiang Z, Nan L, Xu Q, Duan W, Wang Z, Li X, Wu Z, Wu E, Ma Q, Huo X. β2-adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α. Oncotarget 2016;7:17760-72. [PMID: 26497365 DOI: 10.18632/oncotarget.5677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
155 Liang K, Liu F, Fan J, Sun D, Liu C, Lyon CJ, Bernard DW, Li Y, Yokoi K, Katz MH, Koay EJ, Zhao Z, Hu Y. Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring. Nat Biomed Eng 2017;1:0021. [PMID: 28791195 DOI: 10.1038/s41551-016-0021] [Cited by in Crossref: 158] [Cited by in F6Publishing: 190] [Article Influence: 31.6] [Reference Citation Analysis]
156 Fogel EL, Shahda S, Sandrasegaran K, DeWitt J, Easler JJ, Agarwal DM, Eagleson M, Zyromski NJ, House MG, Ellsworth S, El Hajj I, O'Neil BH, Nakeeb A, Sherman S. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review. Am J Gastroenterol. 2017;112:537-554. [PMID: 28139655 DOI: 10.1038/ajg.2016.610] [Cited by in Crossref: 58] [Cited by in F6Publishing: 69] [Article Influence: 11.6] [Reference Citation Analysis]
157 Słotwiński R, Słotwińska SM. Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. Cent Eur J Immunol 2016;41:392-403. [PMID: 28450803 DOI: 10.5114/ceji.2016.65139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
158 Pavlidis ET, Pavlidis TE. Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review. J Invest Surg 2018;31:54-66. [PMID: 28060554 DOI: 10.1080/08941939.2016.1269854] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
159 Boursi B, Finkelman B, Giantonio BJ, Haynes K, Rustgi AK, Rhim AD, Mamtani R, Yang YX. A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. Gastroenterology. 2017;152:840-850.e3. [PMID: 27923728 DOI: 10.1053/j.gastro.2016.11.046] [Cited by in Crossref: 67] [Cited by in F6Publishing: 81] [Article Influence: 11.2] [Reference Citation Analysis]
160 Martin JD, Fukumura D, Duda DG, Boucher Y, Jain RK. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity. Cold Spring Harb Perspect Med 2016;6:a027094. [PMID: 27663981 DOI: 10.1101/cshperspect.a027094] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 9.8] [Reference Citation Analysis]
161 Motallebzadeh R, Aly M, El-Khairi M, Drage M, Olsburgh J, Callaghan CJ. High alcohol intake in deceased donors has no effect on pancreas graft survival: a registry analysis. Transpl Int 2017;30:170-7. [PMID: 27864893 DOI: 10.1111/tri.12890] [Reference Citation Analysis]
162 Kim YW, Lee CH, Jin KN, Lee JK, Heo EY, Park SS, Chung HS, Kim DK. The regional association between bronchiectasis and lung cancer in chest CT. BMC Pulm Med 2016;16:151. [PMID: 27846869 DOI: 10.1186/s12890-016-0311-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
163 Birtolo C, Pham H, Morvaridi S, Chheda C, Go VL, Ptasznik A, Edderkaoui M, Weisman MH, Noss E, Brenner MB, Larson B, Guindi M, Wang Q, Pandol SJ. Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration. Am J Pathol 2017;187:146-55. [PMID: 27855278 DOI: 10.1016/j.ajpath.2016.09.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
164 Pan S, Brentnall TA, Chen R. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol 2016; 22(42): 9288-9299 [PMID: 27895417 DOI: 10.3748/wjg.v22.i42.9288] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
165 Mahesh S, Lekha V, Manipadam JM, Venugopal A, Ramesh H. What can be done when the cored specimen in a Frey procedure for chronic pancreatitis is reported as adenocarcinoma? Indian J Gastroenterol 2016;35:486-8. [PMID: 27783352 DOI: 10.1007/s12664-016-0707-3] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
166 Wang Y, Jin G, Li Q, Wang Z, Hu W, Li P, Li S, Wu H, Kong X, Gao J, Li Z. Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma. J Cancer 2016;7:2067-76. [PMID: 27877222 DOI: 10.7150/jca.15786] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
167 Wodziak D, Dong A, Basin MF, Lowe AW. Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration. PLoS One 2016;11:e0164968. [PMID: 27764193 DOI: 10.1371/journal.pone.0164968] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
168 McWilliams RR, Maisonneuve P, Bamlet WR, Petersen GM, Li D, Risch HA, Yu H, Fontham ET, Luckett B, Bosetti C, Negri E, La Vecchia C, Talamini R, Bueno de Mesquita HB, Bracci P, Gallinger S, Neale RE, Lowenfels AB. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas. 2016;45:311-316. [PMID: 26646264 DOI: 10.1097/mpa.0000000000000392] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 9.7] [Reference Citation Analysis]
169 Vlodavsky I, Singh P, Boyango I, Gutter-Kapon L, Elkin M, Sanderson RD, Ilan N. Heparanase: From basic research to therapeutic applications in cancer and inflammation. Drug Resist Updat. 2016;29:54-75. [PMID: 27912844 DOI: 10.1016/j.drup.2016.10.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 115] [Article Influence: 18.8] [Reference Citation Analysis]
170 Wang J, Hussain SP. NO and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential. Antioxid Redox Signal 2017;26:1000-8. [PMID: 27510096 DOI: 10.1089/ars.2016.6809] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
171 Ikeura T, Miyoshi H, Shimatani M, Uchida K, Takaoka M, Okazaki K. Long-term outcomes of autoimmune pancreatitis. World J Gastroenterol 2016; 22(34): 7760-7766 [PMID: 27678359 DOI: 10.3748/wjg.v22.i34.7760] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
172 Miyoshi E, Kamada Y. Application of glycoscience to the early detection of pancreatic cancer. Cancer Sci 2016;107:1357-62. [PMID: 27418030 DOI: 10.1111/cas.13011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
173 Martinez-Useros J, Garcia-Foncillas J. Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis? Biomed Res Int 2016;2016:4873089. [PMID: 27689078 DOI: 10.1155/2016/4873089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
174 Murakami S, Shahbazian D, Surana R, Zhang W, Chen H, Graham GT, White SM, Weiner LM, Yi C. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene. 2017;36:1232-1244. [PMID: 27546622 DOI: 10.1038/onc.2016.288] [Cited by in Crossref: 79] [Cited by in F6Publishing: 98] [Article Influence: 13.2] [Reference Citation Analysis]
175 Wong CH, Li YJ, Chen YC. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer. World J Gastroenterol 2016; 22(31): 7046-7057 [PMID: 27610015 DOI: 10.3748/wjg.v22.i31.7046] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
176 [DOI: 10.1145/2939672.2939722] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
177 Edgington-Mitchell LE, Wartmann T, Fleming AK, Gocheva V, van der Linden WA, Withana NP, Verdoes M, Aurelio L, Edgington-Mitchell D, Lieu T, Parker BS, Graham B, Reinheckel T, Furness JB, Joyce JA, Storz P, Halangk W, Bogyo M, Bunnett NW. Legumain is activated in macrophages during pancreatitis. Am J Physiol Gastrointest Liver Physiol 2016;311:G548-60. [PMID: 27514475 DOI: 10.1152/ajpgi.00047.2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
178 Wei D, Wang L, Yan Y, Jia Z, Gagea M, Li Z, Zuo X, Kong X, Huang S, Xie K. KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis. Cancer Cell 2016;29:324-38. [PMID: 26977883 DOI: 10.1016/j.ccell.2016.02.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 12.8] [Reference Citation Analysis]
179 Lin PY, Peng SJ, Shen CN, Pasricha PJ, Tang SC. PanIN-associated pericyte, glial, and islet remodeling in mice revealed by 3D pancreatic duct lesion histology. Am J Physiol Gastrointest Liver Physiol 2016;311:G412-22. [PMID: 27340125 DOI: 10.1152/ajpgi.00071.2016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
180 Zhao L, Cai B, Lu Z, Tian L, Guo S, Wu P, Qian D, Xu Q, Jiang K, Miao Y. Modified methods for isolation of pancreatic stellate cells from human and rodent pancreas. J Biomed Res 2016;30:510-6. [PMID: 27924070 DOI: 10.7555/JBR.30.20160033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
181 Pohl JF, Uc A. Paediatric pancreatitis. Curr Opin Gastroenterol. 2015;31:380-386. [PMID: 26181572 DOI: 10.1097/mog.0000000000000197] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 5.2] [Reference Citation Analysis]
182 Dedushi K, Kabashi S, Mucaj S, Hasbahta G, Ramadani N, Hoxhaj A. Imaging Characteristics and Prevalence of Pancreatic Carcinoma in Kosovo During 2011-2015 - Diagnostic Method as Choice. Acta Inform Med 2016;24:162-7. [PMID: 27482128 DOI: 10.5455/aim.2016.24.162-167] [Reference Citation Analysis]
183 Gill JR. Pancreatitis: A Forensic Perspective. Acad Forensic Pathol 2016;6:237-48. [PMID: 31239895 DOI: 10.23907/2016.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
184 Maekawa T, Kamada Y, Ebisutani Y, Ueda M, Hata T, Kawamoto K, Takamatsu S, Mizutani K, Shimomura M, Sobajima T, Fujii H, Nakayama K, Nishino K, Yamada M, Kumada T, Ito T, Eguchi H, Nagano H, Miyoshi E. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. World J Gastroenterol 2016; 22(17): 4403-4410 [PMID: 27158210 DOI: 10.3748/wjg.v22.i17.4403] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
185 Mattheolabakis G, Papayannis I, Yang J, Vaeth BM, Wang R, Bandovic J, Ouyang N, Rigas B, Mackenzie GG. Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice. Cancer Prev Res (Phila) 2016;9:624-34. [PMID: 27138793 DOI: 10.1158/1940-6207.CAPR-15-0344] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
186 Stolzenberg-Solomon RZ, Amundadottir LT. Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am 2015;29:619-40. [PMID: 26226901 DOI: 10.1016/j.hoc.2015.04.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
187 Niess H, Camaj P, Mair R, Renner A, Zhao Y, Jäckel C, Nelson PJ, Jauch KW, Bruns CJ. Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotype. Oncotarget 2015;6:3306-18. [PMID: 25650658 DOI: 10.18632/oncotarget.2494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
188 Caso R, Miller G. Role of tumor associated macrophages in regulating pancreatic cancer progression. World J Immunol 2016; 6(1): 9-18 [DOI: 10.5411/wji.v6.i1.9] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
189 Toste PA, Nguyen AH, Kadera BE, Duong M, Wu N, Gawlas I, Tran LM, Bikhchandani M, Li L, Patel SG, Dawson DW, Donahue TR. Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK. Mol Cancer Res 2016;14:437-47. [PMID: 26979711 DOI: 10.1158/1541-7786.MCR-15-0348] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
190 Zhang Q, Zeng L, Chen Y, Lian G, Qian C, Chen S, Li J, Huang K. Pancreatic Cancer Epidemiology, Detection, and Management. Gastroenterol Res Pract 2016;2016:8962321. [PMID: 26941789 DOI: 10.1155/2016/8962321] [Cited by in Crossref: 75] [Cited by in F6Publishing: 85] [Article Influence: 12.5] [Reference Citation Analysis]
191 Yasaka K, Katsura M, Akahane M, Sato J, Matsuda I, Ohtomo K. Model-based iterative reconstruction and adaptive statistical iterative reconstruction: dose-reduced CT for detecting pancreatic calcification. Acta Radiol Open 2016;5:2058460116628340. [PMID: 27110389 DOI: 10.1177/2058460116628340] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
192 Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, Lee L, Fujiyama T, Hijioka M, Ueda K, Tachibana Y, Sogame Y, Yasuda H, Kato R, Kataoka K, Shiratori K, Sugiyama M, Okazaki K, Kawa S, Tando Y, Kinoshita Y, Watanabe M, Shimosegawa T. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51:85-92. [PMID: 26725837 DOI: 10.1007/s00535-015-1149-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 71] [Article Influence: 14.5] [Reference Citation Analysis]
193 Karki A, Humphrey SE, Steele RE, Hess DA, Taparowsky EJ, Konieczny SF. Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis. PLoS One 2015;10:e0145724. [PMID: 26717480 DOI: 10.1371/journal.pone.0145724] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
194 Lee KE, Spata M, Bayne LJ, Buza EL, Durham AC, Allman D, Vonderheide RH, Simon MC. Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia. Cancer Discov 2016;6:256-69. [PMID: 26715642 DOI: 10.1158/2159-8290.CD-15-0822] [Cited by in Crossref: 104] [Cited by in F6Publishing: 121] [Article Influence: 14.9] [Reference Citation Analysis]
195 Liao J, Hwang SH, Li H, Yang Y, Yang J, Wecksler AT, Liu JY, Hammock BD, Yang GY. Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM. Cancer Lett 2016;371:187-93. [PMID: 26683769 DOI: 10.1016/j.canlet.2015.11.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
196 Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S, Kurtz RC, Olson SH, Rustgi AK, Schwartz AG, Stoffel E, Syngal S, Zogopoulos G, Ali SZ, Axilbund J, Chaffee KG, Chen YC, Cote ML, Childs EJ, Douville C, Goes FS, Herman JM, Iacobuzio-Donahue C, Kramer M, Makohon-Moore A, McCombie RW, McMahon KW, Niknafs N, Parla J, Pirooznia M, Potash JB, Rhim AD, Smith AL, Wang Y, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov. 2016;6:166-175. [PMID: 26658419 DOI: 10.1158/2159-8290.cd-15-0402] [Cited by in Crossref: 180] [Cited by in F6Publishing: 183] [Article Influence: 25.7] [Reference Citation Analysis]
197 Joshi GK, Deitz-McElyea S, Liyanage T, Lawrence K, Mali S, Sardar R, Korc M. Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes. ACS Nano 2015;9:11075-89. [PMID: 26444644 DOI: 10.1021/acsnano.5b04527] [Cited by in Crossref: 147] [Cited by in F6Publishing: 136] [Article Influence: 21.0] [Reference Citation Analysis]
198 Reichert M, Blume K, Kleger A, Hartmann D, von Figura G. Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin. Stem Cells Int 2016;2016:9298535. [PMID: 26681957 DOI: 10.1155/2016/9298535] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
199 Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T, Yfantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back TC, Yanaga K, Hanna N, Alexander HR, Maitra A, Hussain SP. Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer 2013;132:785-94. [PMID: 22821831 DOI: 10.1002/ijc.27736] [Cited by in Crossref: 62] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
200 Das S, Batra SK. Pancreatic cancer metastasis: are we being pre-EMTed. Curr Pharm Des. 2015;21:1249-1255. [PMID: 25506899 DOI: 10.2174/1381612821666141211115234] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
201 Hu C, Hart SN, Bamlet WR, Moore RM, Nandakumar K, Eckloff BW, Lee YK, Petersen GM, McWilliams RR, Couch FJ. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients. Cancer Epidemiol Biomarkers Prev 2016;25:207-11. [PMID: 26483394 DOI: 10.1158/1055-9965.EPI-15-0455] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 11.6] [Reference Citation Analysis]
202 Sekiguchi Y, Shimada A, Matsuzawa M, Imai H, Wakabayashi M, Sugimoto K, Nakamura N, Sawada T, Arita J, Komatsu N, Noguchi M. Occurrence of Carcinoma of the Pancreas Following Nilotinib Therapy for Chronic Myeloid Leukemia: Report of a Case with Review of the Literature. Turk J Haematol 2015;32:257-62. [PMID: 26376592 DOI: 10.4274/tjh.2013.0322] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Goncalves PH, Montezuma-Rusca JM, Yarchoan R, Uldrick TS. Cancer prevention in HIV-infected populations. Semin Oncol 2016;43:173-88. [PMID: 26970136 DOI: 10.1053/j.seminoncol.2015.09.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
204 Rizwani W, Allen AE, Trevino JG. Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge. Cancers (Basel) 2015;7:1785-805. [PMID: 26404380 DOI: 10.3390/cancers7030861] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
205 Prabhu L, Mundade R, Korc M, Loehrer PJ, Lu T. Critical role of NF-κB in pancreatic cancer. Oncotarget 2014;5:10969-75. [PMID: 25473891 DOI: 10.18632/oncotarget.2624] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 11.6] [Reference Citation Analysis]
206 Sahin IH, Geyer AI, Kelly DW, O'Reilly EM. Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management Implications. Clin Colorectal Cancer 2016;15:24-31. [PMID: 26395520 DOI: 10.1016/j.clcc.2015.08.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
207 Cid-Arregui A, Juarez V. Perspectives in the treatment of pancreatic adenocarcinoma. World J Gastroenterol 2015; 21(31): 9297-9316 [PMID: 26309356 DOI: 10.3748/wjg.v21.i31.9297] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 82] [Article Influence: 13.0] [Reference Citation Analysis]
208 Netea-Maier RT, Plantinga TS, van de Veerdonk FL, Smit JW, Netea MG. Modulation of inflammation by autophagy: Consequences for human disease. Autophagy. 2016;12:245-260. [PMID: 26222012 DOI: 10.1080/15548627.2015.1071759] [Cited by in Crossref: 181] [Cited by in F6Publishing: 182] [Article Influence: 25.9] [Reference Citation Analysis]
209 Lin YK, Johnston PC, Arce K, Hatipoglu BA. Chronic Pancreatitis and Diabetes Mellitus. Curr Treat Options Gastroenterol 2015;13:319-31. [PMID: 26084759 DOI: 10.1007/s11938-015-0055-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
210 Muñoz M, Coveñas R. Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach. Cancers (Basel) 2015;7:1215-32. [PMID: 26154566 DOI: 10.3390/cancers7030832] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
211 Shen M, Wu MY, Chen LP, Zhi Q, Gong FR, Chen K, Li DM, Wu Y, Tao M, Li W. Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA. Sci Rep 2015;5:11836. [PMID: 26135631 DOI: 10.1038/srep11836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
212 Wang C, Sun Y, Wu H, Yu S, Zhang L, Meng Y, Liu M, Yang H, Liu P, Mao X, Lu Z, Chen J. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Tumour Biol 2015;36:9447-56. [PMID: 26124009 DOI: 10.1007/s13277-015-3690-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
213 Falzon M, Bhatia V. Role of Parathyroid Hormone-Related Protein Signaling in Chronic Pancreatitis. Cancers (Basel) 2015;7:1091-108. [PMID: 26095761 DOI: 10.3390/cancers7020826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
214 Matsunaga M, Tahara K, Ohta R, Hiroshige S, Nakamura T, Maehara S, Fukuyama S, Anai H. Carcinoma of the ampulla of Vater diagnosed after surgical treatment for Lemmel's syndrome. Int Cancer Conf J 2016;5:57-60. [PMID: 31149425 DOI: 10.1007/s13691-015-0227-5] [Reference Citation Analysis]
215 Dong H, Qian D, Wang Y, Meng L, Chen D, Ji X, Feng W. Survivin expression and serum levels in pancreatic cancer. World J Surg Oncol 2015;13:189. [PMID: 26016480 DOI: 10.1186/s12957-015-0605-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
216 Dzeletovic I, Harrison ME, Crowell MD, Pannala R, Nguyen CC, Wu Q, Faigel DO. Pancreatitis Before Pancreatic Cancer: Clinical Features and Influence on Outcome. J Clin Gastroenterol. 2013;Oct 22; Epub ahead of print. [PMID: 24153158 DOI: 10.1097/mcg.0b013e3182a9f879] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
217 Liang C, Wang Z, Wu L, Wang C, Yu BH, Yao XZ, Wang XL, Li YY. Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene. Tumour Biol 2015;36:7557-68. [PMID: 25916208 DOI: 10.1007/s13277-015-3471-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
218 Pan S, Brentnall TA, Chen R. Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics. 2015;15:2705-2715. [PMID: 25780901 DOI: 10.1002/pmic.201400476] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
219 Dey P, Rachagani S, Vaz AP, Ponnusamy MP, Batra SK. PD2/Paf1 depletion in pancreatic acinar cells promotes acinar-to-ductal metaplasia. Oncotarget 2014;5:4480-91. [PMID: 24947474 DOI: 10.18632/oncotarget.2041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
220 Rahman F, Cotterchio M, Cleary SP, Gallinger S. Association between alcohol consumption and pancreatic cancer risk: a case-control study. PLoS One. 2015;10:e0124489. [PMID: 25856529 DOI: 10.1371/journal.pone.0124489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
221 Weiss FU, Schurmann C, Guenther A, Ernst F, Teumer A, Mayerle J, Simon P, Völzke H, Radke D, Greinacher A, Kuehn JP, Zenker M, Völker U, Homuth G, Lerch MM. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study. Gut 2015;64:646-56. [PMID: 25028398 DOI: 10.1136/gutjnl-2014-306930] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
222 Garcia-Carracedo D, Yu CC, Akhavan N, Fine SA, Schönleben F, Maehara N, Karg DC, Xie C, Qiu W, Fine RL. Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis. PLoS One. 2015;10:e0120851. [PMID: 25803032 DOI: 10.1371/journal.pone.0120851] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
223 Yee NS, Kazi AA, Li Q, Yang Z, Berg A, Yee RK. Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: Required for cancer cell invasion and implicated in tumor growth and metastasis. Biol Open. 2015;4:507-514. [PMID: 25770184 DOI: 10.1242/bio.20137088] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
224 Mrazek AA, Porro LJ, Bhatia V, Falzon M, Spratt H, Zhou J, Chao C, Hellmich MR. Apigenin inhibits pancreatic stellate cell activity in pancreatitis. J Surg Res. 2015;196:8-16. [PMID: 25799526 DOI: 10.1016/j.jss.2015.02.032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
225 Chen SJ, Zhang QB, Zeng LJ, Lian GD, Li JJ, Qian CC, Chen YZ, Chen YT, Huang KH. Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China. Curr Oncol. 2015;22:e11-e19. [PMID: 25684992 DOI: 10.3747/co.22.2150] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
226 Urayama S. Pancreatic cancer early detection: Expanding higher-risk group with clinical and metabolomics parameters. World J Gastroenterol 2015; 21(6): 1707-1717 [PMID: 25684935 DOI: 10.3748/wjg.v21.i6.1707] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
227 Dhar P, Kalghatgi S, Saraf V. Pancreatic cancer in chronic pancreatitis. Indian J Surg Oncol 2015;6:57-62. [PMID: 25937765 DOI: 10.1007/s13193-014-0373-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
228 Alkhateeb A, Zubritsky L, Kinsman B, Leitzel K, Campbell-Baird C, Ali SM, Connor J, Lipton A. Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease. J Gastrointest Cancer. 2014;45:161-167. [PMID: 24446242 DOI: 10.1007/s12029-013-9564-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
229 Paliwal S, Bhaskar S, Chandak GR. Genetic and phenotypic heterogeneity in tropical calcific pancreatitis. World J Gastroenterol 2014; 20(46): 17314-17323 [PMID: 25516642 DOI: 10.3748/wjg.v20.i46.17314] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
230 Lévy P, Domínguez-Muñoz E, Imrie C, Löhr M, Maisonneuve P. Epidemiology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterol J 2014;2:345-54. [PMID: 25360312 DOI: 10.1177/2050640614548208] [Cited by in Crossref: 133] [Cited by in F6Publishing: 97] [Article Influence: 16.6] [Reference Citation Analysis]
231 Nishikawa Y, Tsuji Y, Isoda H, Kodama Y, Chiba T. Perfusion in the tissue surrounding pancreatic cancer and the patient's prognosis. Biomed Res Int 2014;2014:648021. [PMID: 25302302 DOI: 10.1155/2014/648021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
232 Mackenzie GG, Bartels LE, Xie G, Papayannis I, Alston N, Vrankova K, Ouyang N, Rigas B. A novel Ras inhibitor (MDC-1016) reduces human pancreatic tumor growth in mice. Neoplasia 2013;15:1184-95. [PMID: 24204197 DOI: 10.1593/neo.131368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
233 Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11160-11181 [PMID: 25170202 DOI: 10.3748/wjg.v20.i32.11160] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 85] [Article Influence: 10.5] [Reference Citation Analysis]
234 Knab LM, Grippo PJ, Bentrem DJ. Involvement of eicosanoids in the pathogenesis of pancreatic cancer: The roles of cyclooxygenase-2 and 5-lipoxygenase. World J Gastroenterol 2014; 20(31): 10729-10739 [PMID: 25152576 DOI: 10.3748/wjg.v20.i31.10729] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
235 Cao WL, Xiang XH, Chen K, Xu W, Xia SH. Potential role of NADPH oxidase in pathogenesis of pancreatitis. World J Gastrointest Pathophysiol 2014; 5(3): 169-177 [PMID: 25133019 DOI: 10.4291/wjgp.v5.i3.169] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
236 Walker EJ, Ko AH, Holly EA, Bracci PM. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Int J Cancer. 2015;136:E646-E653. [PMID: 25091126 DOI: 10.1002/ijc.29120] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
237 Mondragon A, Davidsson D, Kyriakoudi S, Bertling A, Gomes-Faria R, Cohen P, Rothery S, Chabosseau P, Rutter GA, da Silva Xavier G. Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia. PLoS One 2014;9:e104873. [PMID: 25119717 DOI: 10.1371/journal.pone.0104873] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
238 Mathew E, Collins MA, Fernandez-Barrena MG, Holtz AM, Yan W, Hogan JO, Tata Z, Allen BL, Fernandez-Zapico ME, di Magliano MP. The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling. J Biol Chem 2014;289:27727-43. [PMID: 25104358 DOI: 10.1074/jbc.M114.556563] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
239 Roch A, Teyssedou J, Mutter D, Marescaux J, Pessaux P. Chronic pancreatitis: A surgical disease? Role of the Frey procedure. World J Gastrointest Surg 2014; 6(7): 129-135 [PMID: 25068010 DOI: 10.4240/wjgs.v6.i7.129] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
240 Kong X, Sun T, Kong F, Du Y, Li Z. Chronic Pancreatitis and Pancreatic Cancer. Gastrointest Tumors. 2014;1:123-134. [PMID: 26674754 DOI: 10.1159/000365306] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
241 Yuen A, Díaz B. The impact of hypoxia in pancreatic cancer invasion and metastasis. Hypoxia (Auckl) 2014;2:91-106. [PMID: 27774469 DOI: 10.2147/HP.S52636] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
242 Téllez-Ávila FI, Villalobos-Garita &, Giovannini M, Chan C, Hernández-Calleros J, Uscanga L, Ramírez-Luna M&. Follow-up of patients with pseudotumoral chronic pancreatitis: Outcome and surveillance. World J Gastroenterol 2014; 20(26): 8612-8616 [PMID: 25024616 DOI: 10.3748/wjg.v20.i26.8612] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Folias AE, Penaranda C, Su AL, Bluestone JA, Hebrok M. Aberrant innate immune activation following tissue injury impairs pancreatic regeneration. PLoS One 2014;9:e102125. [PMID: 25010227 DOI: 10.1371/journal.pone.0102125] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
244 Yarandi SS, Runge T, Wang L, Liu Z, Jiang Y, Chawla S, Woods KE, Keilin S, Willingham FF, Xu H, Cai Q. Increased Incidence of Benign Pancreatic Pathology following Pancreaticoduodenectomy for Presumed Malignancy over 10 Years despite Increased Use of Endoscopic Ultrasound. Diagn Ther Endosc 2014;2014:701535. [PMID: 25002810 DOI: 10.1155/2014/701535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
245 Cabrera MC, Tilahun E, Nakles R, Diaz-Cruz ES, Charabaty A, Suy S, Jackson P, Ley L, Slack R, Jha R. Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo Chemoradiation. Front Oncol. 2014;4:102. [PMID: 24847445 DOI: 10.3389/fonc.2014.00102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
246 Dibra D, Mishra L, Li S. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: an under-appreciated symbiotic relationship. Biochim Biophys Acta 2014;1846:152-60. [PMID: 24821201 DOI: 10.1016/j.bbcan.2014.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
247 Harvey AE, Lashinger LM, Hays D, Harrison LM, Lewis K, Fischer SM, Hursting SD. Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner. PLoS One 2014;9:e94151. [PMID: 24804677 DOI: 10.1371/journal.pone.0094151] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
248 Nauck MA, Friedrich N. Do GLP-1-based therapies increase cancer risk? Diabetes Care 2013;36 Suppl 2:S245-52. [PMID: 23882053 DOI: 10.2337/dcS13-2004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
249 Davies CC, Harvey E, McMahon RF, Finegan KG, Connor F, Davis RJ, Tuveson DA, Tournier C. Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma. Cancer Res 2014;74:3344-56. [PMID: 24713432 DOI: 10.1158/0008-5472.CAN-13-2941] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
250 Shi C, Merchant N, Newsome G, Goldenberg DM, Gold DV. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry. Arch Pathol Lab Med. 2014;138:220-228. [PMID: 24476519 DOI: 10.5858/arpa.2013-0056-oa] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
251 Baumgart S, Chen NM, Siveke JT, König A, Zhang JS, Singh SK, Wolf E, Bartkuhn M, Esposito I, Heßmann E, Reinecke J, Nikorowitsch J, Brunner M, Singh G, Fernandez-Zapico ME, Smyrk T, Bamlet WR, Eilers M, Neesse A, Gress TM, Billadeau DD, Tuveson D, Urrutia R, Ellenrieder V. Inflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12D. Cancer Discov 2014;4:688-701. [PMID: 24694735 DOI: 10.1158/2159-8290.CD-13-0593] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 9.4] [Reference Citation Analysis]
252 von Figura G, Morris JP 4th, Wright CV, Hebrok M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut 2014;63:656-64. [PMID: 23645620 DOI: 10.1136/gutjnl-2012-304287] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 12.3] [Reference Citation Analysis]
253 Ling S, Feng T, Jia K, Tian Y, Li Y. Inflammation to cancer: The molecular biology in the pancreas (Review). Oncol Lett 2014;7:1747-54. [PMID: 24932227 DOI: 10.3892/ol.2014.2003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
254 Wood LD. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy. Mol Diagn Ther 2013;17:287-97. [PMID: 23757204 DOI: 10.1007/s40291-013-0043-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
255 Kamisawa T, Okazaki K, Kawa S, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961-970. [PMID: 24639058 DOI: 10.1007/s00535-014-0945-z] [Cited by in Crossref: 140] [Cited by in F6Publishing: 117] [Article Influence: 17.5] [Reference Citation Analysis]
256 Nogueira L, Freedman ND, Engels EA, Warren JL, Castro F, Koshiol J. Gallstones, cholecystectomy, and risk of digestive system cancers. Am J Epidemiol 2014;179:731-9. [PMID: 24470530 DOI: 10.1093/aje/kwt322] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 8.4] [Reference Citation Analysis]
257 Chang MC, Wong JM, Chang YT. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol 2014; 20(9): 2358-2364 [PMID: 24605033 DOI: 10.3748/wjg.v20.i9.2358] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
258 Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in pancreatic cancer. World J Gastroenterol 2014; 20(9): 2321-2334 [PMID: 24605029 DOI: 10.3748/wjg.v20.i9.2321] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
259 Rustgi AK. Familial pancreatic cancer: genetic advances. Genes Dev. 2014;28:1-7. [PMID: 24395243 DOI: 10.1101/gad.228452.113] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]
260 Zhang Y, Yan W, Mathew E, Bednar F, Wan S, Collins MA, Evans RA, Welling TH, Vonderheide RH, di Magliano MP. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Immunol Res 2014;2:423-35. [PMID: 24795355 DOI: 10.1158/2326-6066.CIR-14-0016-T] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
261 Zhao LL, Zhang T, Liu BR, Liu TF, Tao N, Zhuang LW. Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level. Mol Biol Rep 2014;41:2875-83. [PMID: 24469724 DOI: 10.1007/s11033-014-3143-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
262 Collins MA, Pasca di Magliano M. Kras as a key oncogene and therapeutic target in pancreatic cancer. Front Physiol. 2013;4:407. [PMID: 24478710 DOI: 10.3389/fphys.2013.00407] [Cited by in Crossref: 38] [Cited by in F6Publishing: 68] [Article Influence: 4.8] [Reference Citation Analysis]
263 Sun H, Han B, Cheng X, Ma K. Transcriptional regulatory network and protein-protein interaction to reveal the mechanism of pancreatic cancer. Mol Biol Rep 2014;41:387-95. [PMID: 24307251 DOI: 10.1007/s11033-013-2872-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
264 Collins MA, Yan W, Sebolt-Leopold JS, Pasca di Magliano M. MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice. Gastroenterology. 2014;146:822-834.e7. [PMID: 24315826 DOI: 10.1053/j.gastro.2013.11.052] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
265 Hart PA, Kamisawa T, Brugge WR, Chung JB, Culver EL, Czakó L, Frulloni L, Go VL, Gress TM, Kim MH, Kawa S, Lee KT, Lerch MM, Liao WC, Löhr M, Okazaki K, Ryu JK, Schleinitz N, Shimizu K, Shimosegawa T, Soetikno R, Webster G, Yadav D, Zen Y, Chari ST. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-6. [PMID: 23232048 DOI: 10.1136/gutjnl-2012-303617] [Cited by in Crossref: 351] [Cited by in F6Publishing: 281] [Article Influence: 39.0] [Reference Citation Analysis]
266 Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R, Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD, Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E, Dorronsoro M, Quirós JR, Duell EJ, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Bueno-de-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013;62:1764-70. [PMID: 22990306 DOI: 10.1136/gutjnl-2012-303006] [Cited by in Crossref: 217] [Cited by in F6Publishing: 212] [Article Influence: 24.1] [Reference Citation Analysis]
267 Ewald N, Hardt PD. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol 2013; 19(42): 7276-7281 [PMID: 24259958 DOI: 10.3748/wjg.v19.i42.7276] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 90] [Article Influence: 12.3] [Reference Citation Analysis]
268 García-Pravia C, Galván JA, Gutiérrez-Corral N, Solar-García L, García-Pérez E, García-Ocaña M, Del Amo-Iribarren J, Menéndez-Rodríguez P, García-García J, de Los Toyos JR, Simón-Buela L, Barneo L. Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer. PLoS One 2013;8:e78327. [PMID: 24194920 DOI: 10.1371/journal.pone.0078327] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
269 Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 2013;73:6359-74. [PMID: 24097820 DOI: 10.1158/0008-5472.CAN-13-1558-T] [Cited by in Crossref: 133] [Cited by in F6Publishing: 155] [Article Influence: 14.8] [Reference Citation Analysis]
270 Rebours V, Albuquerque M, Sauvanet A, Ruszniewski P, Lévy P, Paradis V, Bedossa P, Couvelard A. Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas. PLoS One. 2013;8:e76229. [PMID: 24098783 DOI: 10.1371/journal.pone.0076229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
271 Gnoni A, Licchetta A, Scarpa A, Azzariti A, Brunetti AE, Simone G, Nardulli P, Santini D, Aieta M, Delcuratolo S, Silvestris N. Carcinogenesis of pancreatic adenocarcinoma: precursor lesions. Int J Mol Sci. 2013;14:19731-19762. [PMID: 24084722 DOI: 10.3390/ijms141019731] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
272 Blanco A, de la Hoya M, Osorio A, Diez O, Miramar MD, Infante M, Martinez-Bouzas C, Torres A, Lasa A, Llort G, Brunet J, Graña B, Perez Segura P, Garcia MJ, Gutiérrez-Enríquez S, Carracedo Á, Tejada MI, Velasco EA, Calvo MT, Balmaña J, Benitez J, Caldés T, Vega A. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases. PLoS One 2013;8:e67538. [PMID: 23935836 DOI: 10.1371/journal.pone.0067538] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
273 Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis. 2013;34:2193-2197. [PMID: 23843038 DOI: 10.1093/carcin/bgt249] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 8.8] [Reference Citation Analysis]
274 Apte MV, Wilson JS, Lugea A, Pandol SJ. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology. 2013;144:1210-1219. [PMID: 23622130 DOI: 10.1053/j.gastro.2012.11.037] [Cited by in Crossref: 249] [Cited by in F6Publishing: 276] [Article Influence: 27.7] [Reference Citation Analysis]
275 Raissouni S, Rais G, Mrabti H, Raissouni F, Mouzount H, Aitelhaj M, El Khoyaali S, Mohtaram A, Errihani H. Pancreatic adenocarcinoma in young adults in a moroccan population. J Gastrointest Cancer 2012;43:607-11. [PMID: 22760710 DOI: 10.1007/s12029-012-9407-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
276 Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: why, how, and who? Ann Surg 2013;257:17-26. [PMID: 22895395 DOI: 10.1097/SLA.0b013e31825ffbfb] [Cited by in Crossref: 120] [Cited by in F6Publishing: 64] [Article Influence: 13.3] [Reference Citation Analysis]
277 Bailey CJ. Interpreting adverse signals in diabetes drug development programs. Diabetes Care 2013;36:2098-106. [PMID: 23695817 DOI: 10.2337/dc13-0182] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
278 Perumal S, Palaniappan R, Pillai SA, Velayutham V, Sathyanesan J. Predictors of malignancy in chronic calcific pancreatitis with head mass. World J Gastrointest Surg 2013; 5(4): 97-103 [PMID: 23717745 DOI: 10.4240/wjgs.v5.i4.97] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
279 Scarlett CJ. Contribution of bone marrow derived cells to the pancreatic tumor microenvironment. Front Physiol. 2013;4:56. [PMID: 23531764 DOI: 10.3389/fphys.2013.00056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
280 Goldberg R, Meirovitz A, Hirshoren N, Bulvik R, Binder A, Rubinstein AM, Elkin M. Versatile role of heparanase in inflammation. Matrix Biol. 2013;32:234-240. [PMID: 23499528 DOI: 10.1016/j.matbio.2013.02.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 81] [Article Influence: 9.7] [Reference Citation Analysis]
281 Meirovitz A, Goldberg R, Binder A, Rubinstein AM, Hermano E, Elkin M. Heparanase in inflammation and inflammation-associated cancer. FEBS J 2013;280:2307-19. [PMID: 23398975 DOI: 10.1111/febs.12184] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
282 Tang D, Wang D, Yuan Z, Xue X, Zhang Y, An Y, Chen J, Tu M, Lu Z, Wei J, Jiang K, Miao Y. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer 2013;132:993-1003. [PMID: 22777597 DOI: 10.1002/ijc.27715] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 7.6] [Reference Citation Analysis]
283 Denley SM, Jamieson NB, McCall P, Oien KA, Morton JP, Carter CR, Edwards J, McKay CJ. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17:887-898. [PMID: 23435739 DOI: 10.1007/s11605-013-2168-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.7] [Reference Citation Analysis]
284 Nieß H, Albertsmeier M, Thomas M, Kleespies A, Angele M, Bruns CJ. [Chronic pancreatitis or pancreatic malignancy: clinical and radiological differential diagnosis of pancreas head space-occupying mass]. Chirurg 2013;84:106-11. [PMID: 23400785 DOI: 10.1007/s00104-012-2374-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
285 Guerra C, Barbacid M. Genetically engineered mouse models of pancreatic adenocarcinoma. Mol Oncol 2013;7:232-47. [PMID: 23506980 DOI: 10.1016/j.molonc.2013.02.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 11.3] [Reference Citation Analysis]
286 Herreros-Villanueva M, Hijona E, Bañales JM, Cosme A, Bujanda L. Alcohol consumption on pancreatic diseases. World J Gastroenterol 2013; 19(5): 638-647 [PMID: 23429423 DOI: 10.3748/wjg.v19.i5.638] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.2] [Reference Citation Analysis]
287 DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol. 2012;28:523-531. [PMID: 22782018 DOI: 10.1097/mog.0b013e3283567dea] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
288 Steele CW, Jamieson NB, Evans TR, McKay CJ, Sansom OJ, Morton JP, Carter CR. Exploiting inflammation for therapeutic gain in pancreatic cancer. Br J Cancer. 2013;108:997-1003. [PMID: 23385734 DOI: 10.1038/bjc.2013.24] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
289 Banerjee A, Onyuksel H. A novel peptide nanomedicine for treatment of pancreatogenic diabetes. Nanomedicine 2013;9:722-8. [PMID: 23347897 DOI: 10.1016/j.nano.2012.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
290 He K, Xun P, Brasky TM, Gammon MD, Stevens J, White E. Types of fish consumed and fish preparation methods in relation to pancreatic cancer incidence: the VITAL Cohort Study. Am J Epidemiol 2013;177:152-60. [PMID: 23221729 DOI: 10.1093/aje/kws232] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
291 Ochi A, Graffeo CS, Zambirinis CP, Rehman A, Hackman M, Fallon N, Barilla RM, Henning JR, Jamal M, Rao R. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J Clin Invest. 2012;122:4118-4129. [PMID: 23023703 DOI: 10.1172/jci63606] [Cited by in Crossref: 119] [Cited by in F6Publishing: 124] [Article Influence: 13.2] [Reference Citation Analysis]
292 Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res. 2012;18:4266-4276. [PMID: 22896693 DOI: 10.1158/1078-0432.ccr-11-3114] [Cited by in Crossref: 711] [Cited by in F6Publishing: 765] [Article Influence: 79.0] [Reference Citation Analysis]
293 Pan S, Brentnall TA, Kelly K, Chen R. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Proteomics. 2013;13:710-721. [PMID: 23125171 DOI: 10.1002/pmic.201200319] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
294 Wörmann SM, Algül H. Risk Factors and Therapeutic Targets in Pancreatic Cancer. Front Oncol 2013;3. [DOI: 10.3389/fonc.2013.00282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
295 Kopp JL, von Figura G, Mayes E, Liu FF, Dubois CL, Morris JP 4th, Pan FC, Akiyama H, Wright CV, Jensen K, Hebrok M, Sander M. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;22:737-750. [PMID: 23201164 DOI: 10.1016/j.ccr.2012.10.025] [Cited by in Crossref: 388] [Cited by in F6Publishing: 357] [Article Influence: 38.8] [Reference Citation Analysis]
296 Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomark 2011-2012;11:1-14. [PMID: 22820136 DOI: 10.3233/CBM-2012-0260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
297 Taudien S, Gäbel G, Kuss O, Groth M, Grützmann R, Huse K, Kluttig A, Wolf A, Nothnagel M, Rosenstiel P, Greiser KH, Werdan K, Krawczak M, Pilarsky C, Platzer M. Association studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis. BMC Res Notes 2012;5:629. [PMID: 23148552 DOI: 10.1186/1756-0500-5-629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
298 Graziani R, Frulloni L, Cicero C, Manfredi R, Ambrosetti MC, Mautone S, Pozzi Mucelli R. Bull's-eye pattern of pancreatic-duct stones on multidetector computed tomography and gene-mutation-associated pancreatitis (GMAP). Radiol Med 2012;117:1275-86. [PMID: 23090249 DOI: 10.1007/s11547-012-0888-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
299 Mirrakhimov AE, Khan FN. Epidural brain metastases in a patient with early onset pancreatic cancer: a case report and literature review. Case Rep Oncol Med 2012;2012:962305. [PMID: 23119207 DOI: 10.1155/2012/962305] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
300 Lai HC, Tsai IJ, Chen PC, Muo CH, Chou JW, Peng CY, Lai SW, Sung FC, Lyu SY, Morisky DE. Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population-based cohort study. J Gastroenterol 2013;48:721-7. [PMID: 23053420 DOI: 10.1007/s00535-012-0674-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
301 Erkan M, Hausmann S, Michalski CW, Schlitter AM, Fingerle AA, Dobritz M, Friess H, Kleeff J. How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol. 2012;3:389. [PMID: 23060813 DOI: 10.3389/fphys.2012.00389] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
302 Loos M, Michalski CW, Kleeff J. Asymptomatic pancreatic lesions: New insights and clinical implications. World J Gastroenterol 2012; 18(33): 4474-4477 [PMID: 22969218 DOI: 10.3748/wjg.v18.i33.4474] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
303 Mokmak W, Chunsrivirot S, Assawamakin A, Choowongkomon K, Tongsima S. Molecular dynamics simulations reveal structural instability of human trypsin inhibitor upon D50E and Y54H mutations. J Mol Model 2013;19:521-8. [PMID: 22955423 DOI: 10.1007/s00894-012-1565-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
304 Anderson MA, Zolotarevsky E, Cooper KL, Sherman S, Shats O, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Vogel KJ, Sasson AR, Grizzle WE, Ketcham MA, Lee SY, Normolle D, Plonka CM, Mertens AN, Tripon RC, Brand RE. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol 2012;107:1730-9. [PMID: 22929760 DOI: 10.1038/ajg.2012.288] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
305 Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: An overview. J Gastrointest Oncol 2011;2:168-74. [PMID: 22811847 DOI: 10.3978/j.issn.2078-6891.2011.036] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
306 Gold DV, Gaedcke J, Ghadimi BM, Goggins M, Hruban RH, Liu M, Newsome G, Goldenberg DM. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma. Cancer 2013;119:522-8. [PMID: 22898932 DOI: 10.1002/cncr.27762] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
307 Pandol SJ, Apte MV, Wilson JS, Gukovskaya AS, Edderkaoui M. The burning question: why is smoking a risk factor for pancreatic cancer? Pancreatology 2012;12:344-9. [PMID: 22898636 DOI: 10.1016/j.pan.2012.06.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
308 Evans A, Costello E. The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol. 2012;3:270. [PMID: 22969725 DOI: 10.3389/fphys.2012.00270] [Cited by in Crossref: 11] [Cited by in F6Publishing: 44] [Article Influence: 1.1] [Reference Citation Analysis]
309 Al-Wadei MH, Al-Wadei HA, Schuller HM. Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters. Carcinogenesis 2012;33:1745-53. [PMID: 22791813 DOI: 10.1093/carcin/bgs229] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
310 Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, Ludwig E, Yu H, Lowenfels AB, Seminara D, Petersen GM, La Vecchia C, Boffetta P. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012;23:2964-2970. [PMID: 22767586 DOI: 10.1093/annonc/mds140] [Cited by in Crossref: 139] [Cited by in F6Publishing: 131] [Article Influence: 13.9] [Reference Citation Analysis]
311 Goggins M. GLP-1 receptor agonist effects on normal and neoplastic pancreata. Diabetes. 2012;61:989-990. [PMID: 22517654 DOI: 10.2337/db12-0233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
312 Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9:454-467. [PMID: 22710569 DOI: 10.1038/nrgastro.2012.115] [Cited by in Crossref: 401] [Cited by in F6Publishing: 384] [Article Influence: 40.1] [Reference Citation Analysis]
313 Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012;9:454-67. [PMID: 22710569 DOI: 10.1038/nrgastro.2012.115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
314 Pandol S, Gukovskaya A, Edderkaoui M, Dawson D, Eibl G, Lugea A. Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell. J Gastroenterol Hepatol. 2012;27 Suppl 2:127-134. [PMID: 22320930 DOI: 10.1111/j.1440-1746.2011.07013.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
315 Amedei A, Della Bella C, Silvestri E, Prisco D, D'Elios MM. T cells in gastric cancer: friends or foes. Clin Dev Immunol. 2012;2012:690571. [PMID: 22693525 DOI: 10.1155/2012/690571] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
316 Kirkegaard J. Incidence of pancreatic cancer in Greenland 2000-2010. Int J Circumpolar Health 2012;71:18368. [PMID: 22663941 DOI: 10.3402/ijch.v71i0.18368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
317 Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol. 2013;107:1-7. [PMID: 22589078 DOI: 10.1002/jso.23149] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
318 Ward ST, Dangi-Garimella S, Shields MA, Collander BA, Siddiqui MA, Krantz SB, Munshi HG. Ethanol differentially regulates snail family of transcription factors and invasion of premalignant and malignant pancreatic ductal cells. J Cell Biochem 2011;112:2966-73. [PMID: 21678462 DOI: 10.1002/jcb.23215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
319 Rosso M, Muñoz M, Berger M. The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer. ScientificWorldJournal 2012;2012:381434. [PMID: 22545017 DOI: 10.1100/2012/381434] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
320 Wittel UA, Momi N, Seifert G, Wiech T, Hopt UT, Batra SK. The pathobiological impact of cigarette smoke on pancreatic cancer development (review). Int J Oncol 2012;41:5-14. [PMID: 22446714 DOI: 10.3892/ijo.2012.1414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 0.2] [Reference Citation Analysis]
321 Greer JB, LaRusch J, Brand RE, O’Connell MR, Yadav D, Whitcomb DC. ABO blood group and chronic pancreatitis risk in the NAPS2 cohort. Pancreas. 2011;40:1188-1194. [PMID: 21792085 DOI: 10.1097/mpa.0b013e3182232975] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
322 Pan S, Chen R, Brand RE, Hawley S, Tamura Y, Gafken PR, Milless BP, Goodlett DR, Rush J, Brentnall TA. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012;11:1937-1948. [PMID: 22316387 DOI: 10.1021/pr201117w] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
323 Iovanna J, Mallmann MC, Gonçalves A, Turrini O, Dagorn JC. Current knowledge on pancreatic cancer. Front Oncol. 2012;2:6. [PMID: 22655256 DOI: 10.3389/fonc.2012.00006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
324 Lin WR, Inatomi O, Lee CY, Kallis YN, Otto WR, Jeffery R, Poulsom R, Alison MR. Bone marrow-derived cells contribute to cerulein-induced pancreatic fibrosis in the mouse. Int J Exp Pathol. 2012;93:130-138. [PMID: 22283686 DOI: 10.1111/j.1365-2613.2011.00804.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
325 Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M; American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology. 2012;142:796-804; quiz e14-5. [PMID: 22245846 DOI: 10.1053/j.gastro.2012.01.005] [Cited by in Crossref: 386] [Cited by in F6Publishing: 432] [Article Influence: 38.6] [Reference Citation Analysis]
326 Chung YT, Matkowskyj KA, Li H, Bai H, Zhang W, Tsao MS, Liao J, Yang GY. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma. Mod Pathol. 2012;25:758-766. [PMID: 22222635 DOI: 10.1038/modpathol.2011.191] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
327 Pan S, Chen R, Stevens T, Bronner MP, May D, Tamura Y, McIntosh MW, Brentnall TA. Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One. 2011;6:e27574. [PMID: 22132114 DOI: 10.1371/journal.pone.0027574] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
328 Yashima Y, Sasahira N, Isayama H, Kogure H, Ikeda H, Hirano K, Mizuno S, Yagioka H, Kawakubo K, Sasaki T. Acoustic radiation force impulse elastography for noninvasive assessment of chronic pancreatitis. J Gastroenterol. 2012;47:427-432. [PMID: 22065162 DOI: 10.1007/s00535-011-0491-x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 6.7] [Reference Citation Analysis]
329 Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, Abbruzzese JL, Liu YJ, Logsdon CD, Hwu P. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2011;17:7015-7023. [PMID: 21976550 DOI: 10.1158/1078-0432.ccr-11-0607] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 8.1] [Reference Citation Analysis]
330 Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández-Porras I, Cañamero M, Rodriguez-Justo M, Serrano M, Barbacid M. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011;19:728-39. [PMID: 21665147 DOI: 10.1016/j.ccr.2011.05.011] [Cited by in Crossref: 316] [Cited by in F6Publishing: 292] [Article Influence: 28.7] [Reference Citation Analysis]
331 Won JH, Zhang Y, Ji B, Logsdon CD, Yule DI. Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitis. Mol Biol Cell. 2011;22:421-436. [PMID: 21148289 DOI: 10.1091/mbc.e10-10-0807] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
332 Sutherland T, Galvin A, Little AF. Part 2: CT characterisation of pancreatic neoplasm: tumour mimics. Insights Imaging 2011;2:389-97. [PMID: 22347960 DOI: 10.1007/s13244-011-0103-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
333 Lashinger LM, Malone LM, McArthur MJ, Goldberg JA, Daniels EA, Pavone A, Colby JK, Smith NC, Perkins SN, Fischer SM. Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2-driven pancreatic neoplasia. Cancer Prev Res (Phila). 2011;4:1030-1040. [PMID: 21593196 DOI: 10.1158/1940-6207.CAPR-11-0027] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
334 Rutter K, Ferlitsch A, Sautner T, Püspök A, Götzinger P, Gangl A, Schindl M. Hospitalization, frequency of interventions, and quality of life after endoscopic, surgical, or conservative treatment in patients with chronic pancreatitis. World J Surg. 2010;34:2642-2647. [PMID: 20645098 DOI: 10.1007/s00268-010-0713-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
335 Pandol SJ, Gorelick FS, Lugea A. Environmental and genetic stressors and the unfolded protein response in exocrine pancreatic function - a hypothesis. Front Physiol. 2011;2:8. [PMID: 21483727 DOI: 10.3389/fphys.2011.00008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
336 Kant P, Hull MA. Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol. 2011;8:224-238. [PMID: 21386810 DOI: 10.1038/nrgastro.2011.23] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 7.5] [Reference Citation Analysis]
337 Nandy D, Mukhopadhyay D. Growth factor mediated signaling in pancreatic pathogenesis. Cancers (Basel) 2011;3:841-71. [PMID: 24212642 DOI: 10.3390/cancers3010841] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
338 Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol 2011; 17(7): 867-897 [PMID: 21412497 DOI: 10.3748/wjg.v17.i7.867] [Cited by in CrossRef: 132] [Cited by in F6Publishing: 120] [Article Influence: 12.0] [Reference Citation Analysis]
339 Pandol SJ, Lugea A, Mareninova OA, Smoot D, Gorelick FS, Gukovskaya AS, Gukovsky I. Investigating the pathobiology of alcoholic pancreatitis. Alcohol Clin Exp Res 2011;35:830-7. [PMID: 21284675 DOI: 10.1111/j.1530-0277.2010.01408.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
340 Lee KE, Bar-Sagi D. Oncogenic KRas suppresses inflammation-associated senescence of pancreatic ductal cells. Cancer Cell. 2010;18:448-458. [PMID: 21075310 DOI: 10.1016/j.ccr.2010.10.020] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 7.8] [Reference Citation Analysis]
341 Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW 2nd, Malafa MP, Muscarella P 2nd, Nakakura EK, Sasson AR, Thayer SP, Tyler DS, Warren RS, Whiting S, Willett C, Wolff RA; NCCN Pancreatic Adenocarcinoma. Pancreatic adenocarcinoma. J Natl Compr Canc Netw 2010;8:972-1017. [PMID: 20876541 DOI: 10.6004/jnccn.2010.0073] [Cited by in Crossref: 122] [Cited by in F6Publishing: 118] [Article Influence: 10.2] [Reference Citation Analysis]
342 Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP. Update on familial pancreatic cancer. Adv Surg. 2010;44:293-311. [PMID: 20919528 DOI: 10.1016/j.yasu.2010.05.011] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 13.3] [Reference Citation Analysis]
343 Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta 2011;1815:44-64. [PMID: 20888394 DOI: 10.1016/j.bbcan.2010.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 57] [Article Influence: 1.8] [Reference Citation Analysis]
344 Pickartz T, Mayerle J, Kraft M, Evert M, Evert K, Kühn JP, Heidecke CD, Lerch MM. [Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges]. Med Klin (Munich) 2010;105:281-5. [PMID: 20455050 DOI: 10.1007/s00063-010-1042-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
345 Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer 2010;127:1893-904. [PMID: 20104522 DOI: 10.1002/ijc.25208] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
346 Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479-496. [PMID: 20370557 DOI: 10.3109/10715761003667554] [Cited by in Crossref: 1531] [Cited by in F6Publishing: 1671] [Article Influence: 127.6] [Reference Citation Analysis]
347 Habisch H, Zhou S, Siech M, Bachem MG. Interaction of stellate cells with pancreatic carcinoma cells. Cancers (Basel). 2010;2:1661-1682. [PMID: 24281180 DOI: 10.3390/cancers2031661] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
348 Morris JP 4th, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 2010;10:683-695. [PMID: 20814421 DOI: 10.1038/nrc2899] [Cited by in Crossref: 381] [Cited by in F6Publishing: 379] [Article Influence: 31.8] [Reference Citation Analysis]
349 Gold DV, Goggins M, Modrak DE, Newsome G, Liu M, Shi C, Hruban RH, Goldenberg DM. Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2010;19:2786-2794. [PMID: 20810605 DOI: 10.1158/1055-9965.epi-10-0667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
350 Low SK, Kuchiba A, Zembutsu H, Saito A, Takahashi A, Kubo M, Daigo Y, Kamatani N, Chiku S, Totsuka H, Ohnami S, Hirose H, Shimada K, Okusaka T, Yoshida T, Nakamura Y, Sakamoto H. Genome-wide association study of pancreatic cancer in Japanese population. PLoS One. 2010;5:e11824. [PMID: 20686608 DOI: 10.1371/journal.pone.0011824] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
351 Ferrone C, Dranoff G. Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 2010;28:4045-51. [PMID: 20644090 DOI: 10.1200/JCO.2010.27.9992] [Cited by in Crossref: 115] [Cited by in F6Publishing: 143] [Article Influence: 9.6] [Reference Citation Analysis]
352 Paramythiotis D, Kleeff J, Schmidt J, Büchler MW, Friess H. Detection of oncogenes in chronic pancreatitis. HPB (Oxford) 2003;5:214-25. [PMID: 18332990 DOI: 10.1080/13651820310017804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
353 Abdallah AA, Krige JE, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford). 2007;9:421-428. [PMID: 18345288 DOI: 10.1080/13651820701774883] [Cited by in Crossref: 82] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
354 Rubie C, Frick VO, Ghadjar P, Wagner M, Grimm H, Vicinus B, Justinger C, Graeber S, Schilling MK. CCL20/CCR6 expression profile in pancreatic cancer. J Transl Med. 2010;8:45. [PMID: 20459729 DOI: 10.1186/1479-5876-8-45] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
355 Ozhan G, Yanar HT, Ertekin C, Alpertunga B. Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis. Mediators Inflamm 2010;2010:482950. [PMID: 20396411 DOI: 10.1155/2010/482950] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
356 Gupta S, Wang F, Holly EA, Bracci PM. Risk of pancreatic cancer by alcohol dose, duration, and pattern of consumption, including binge drinking: a population-based study. Cancer Causes Control. 2010;21:1047-1059. [PMID: 20349126 DOI: 10.1007/s10552-010-9533-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
357 Gerloff A, Singer MV, Feick P. Beer and its non-alcoholic compounds: role in pancreatic exocrine secretion, alcoholic pancreatitis and pancreatic carcinoma. Int J Environ Res Public Health 2010;7:1093-104. [PMID: 20617020 DOI: 10.3390/ijerph7031093] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
358 Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M; Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010;45:471-7. [DOI: 10.1007/s00535-010-0221-9] [Cited by in Crossref: 188] [Cited by in F6Publishing: 155] [Article Influence: 15.7] [Reference Citation Analysis]
359 McWilliams RR, Petersen GM, Rabe KG, Holtegaard LM, Lynch PJ, Bishop MD, Highsmith WE. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer. 2010;116:203-209. [PMID: 19885835 DOI: 10.1002/cncr.24697] [Cited by in Crossref: 13] [Cited by in F6Publishing: 39] [Article Influence: 1.1] [Reference Citation Analysis]
360 Kamisawa T, Horiguchi S, Hayashi Y, Yun X, Yamaguchi T, Tsuruta K, Sasaki T. K-ras mutation in the major duodenal papilla and gastric and colonic mucosa in patients with autoimmune pancreatitis. J Gastroenterol. 2010;45:771-778. [PMID: 20157749 DOI: 10.1007/s00535-010-0211-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
361 Logsdon CD, Ji B. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:S40-S43. [PMID: 19896097 DOI: 10.1016/j.cgh.2009.07.040] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
362 Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2009;7:S44-S47. [PMID: 19896098 DOI: 10.1016/j.cgh.2009.07.039] [Cited by in Crossref: 135] [Cited by in F6Publishing: 131] [Article Influence: 11.3] [Reference Citation Analysis]
363 Calculli L, Pezzilli R, Brindisi C, Morabito R, Casadei R, Zompatori M. Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience. Radiol Med. 2010;115:442-452. [PMID: 20082228 DOI: 10.1007/s11547-010-0502-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
364 Morris JP 4th, Cano DA, Sekine S, Wang SC, Hebrok M. Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest. 2010;120:508-520. [PMID: 20071774 DOI: 10.1172/jci40045] [Cited by in Crossref: 233] [Cited by in F6Publishing: 231] [Article Influence: 19.4] [Reference Citation Analysis]
365 Bracci PM, Wang F, Hassan MM, Gupta S, Li D, Holly EA. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control. 2009;20:1723-1731. [PMID: 19760029 DOI: 10.1007/s10552-009-9424-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
366 Inui K, Igarashi Y, Irisawa A, Ohara H, Tazuma S, Hirooka Y, Fujita N, Miyakawa H, Sata N, Shimosegawa T. Japanese guidelines for the endoscopic management of pancreatic stone. Journal of the Japan Pancreas Society 2010;25:553-77. [DOI: 10.2958/suizo.25.553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
367 Büchler MW, Martignoni ME, Friess H, Malfertheiner P. A proposal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol. 2009;9:93. [PMID: 20003450 DOI: 10.1186/1471-230x-9-93] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
368 Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, Schulick R, Palmisano E, Hruban RH. Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients. Clin Cancer Res 2009;15:7737-43. [PMID: 19996207 DOI: 10.1158/1078-0432.CCR-09-0004] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 11.5] [Reference Citation Analysis]
369 Mihaljevic AL, Esposito I, Friess H, Kleeff J. Molecular biology, models, and histopathology of chronic pancreatitis and pancreatic cancer. Eur Surg 2009;41:250-67. [DOI: 10.1007/s10353-009-0496-3] [Reference Citation Analysis]
370 Pezzilli R, Morselli-Labate AM. Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain. Int J Environ Res Public Health. 2009;6:2763-2782. [PMID: 20049222 DOI: 10.3390/ijerph6112763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
371 Couch FJ, Wang X, McWilliams RR, Bamlet WR, de Andrade M, Petersen GM. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3044-8. [PMID: 19843670 DOI: 10.1158/1055-9965.EPI-09-0306] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
372 Pezzilli R. Etiology of chronic pancreatitis: Has it changed in the last decade? World J Gastroenterol 2009; 15(38): 4737-4740 [PMID: 19824104 DOI: 10.3748/wjg.15.4737] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
373 Bao Y, Spiegelman D, Li R, Giovannucci E, Fuchs CS, Michaud DS. History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology. 2010;138:541-549. [PMID: 19818786 DOI: 10.1053/j.gastro.2009.09.059] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
374 Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009;6:699-708. [PMID: 19806144 DOI: 10.1038/nrgastro.2009.177] [Cited by in Crossref: 421] [Cited by in F6Publishing: 391] [Article Influence: 32.4] [Reference Citation Analysis]
375 Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699-708. [PMID: 19806144 DOI: 10.1038/nrgastro.2009.17] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
376 Zhang H, Ables ET, Pope CF, Washington MK, Hipkens S, Means AL, Path G, Seufert J, Costa RH, Leiter AB, Magnuson MA, Gannon M. Multiple, temporal-specific roles for HNF6 in pancreatic endocrine and ductal differentiation. Mech Dev 2009;126:958-73. [PMID: 19766716 DOI: 10.1016/j.mod.2009.09.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
377 Schima W, Ba-Ssalamah A, Plank C, Kulinna-Cosentini C, Püspök A. [Pancreas. Congenital changes, acute and chronic pancreatitis]. Radiologe 2007;47 Suppl 1:S41-55; quiz S56. [PMID: 17468982 DOI: 10.1007/s00117-007-1497-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
378 Chipitsyna G, Gong Q, Anandanadesan R, Alnajar A, Batra SK, Wittel UA, Cullen DM, Akhter MP, Denhardt DT, Yeo CJ. Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells. Int J Cancer. 2009;125:276-285. [PMID: 19358273 DOI: 10.1002/ijc.24388] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
379 Sharma RR, London MJ, Magenta LL, Posner MC, Roggin KK. Preemptive surgery for premalignant foregut lesions. J Gastrointest Surg. 2009;13:1874-1887. [PMID: 19513795 DOI: 10.1007/s11605-009-0935-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
380 Bedi MM, Gandhi MD, Jacob G, Lekha V, Venugopal A, Ramesh H. CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J Gastroenterol. 2009;28:24-27. [PMID: 19529898 DOI: 10.1007/s12664-009-0005-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
381 Heinen MM, Verhage BA, Ambergen TA, Goldbohm RA, van den Brandt PA. Alcohol consumption and risk of pancreatic cancer in the Netherlands cohort study. Am J Epidemiol 2009;169:1233-42. [PMID: 19318612 DOI: 10.1093/aje/kwp028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
382 Jiao L, Silverman DT, Schairer C, Thiébaut AC, Hollenbeck AR, Leitzmann MF, Schatzkin A, Stolzenberg-Solomon RZ. Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2009;169:1043-51. [PMID: 19299403 DOI: 10.1093/aje/kwp034] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
383 Matveyenko AV, Dry S, Cox HI, Moshtaghian A, Gurlo T, Galasso R, Butler AE, Butler PC. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes 2009;58:1604-15. [PMID: 19403868 DOI: 10.2337/db09-0058] [Cited by in Crossref: 174] [Cited by in F6Publishing: 176] [Article Influence: 13.4] [Reference Citation Analysis]
384 Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. 2009;133:365-374. [PMID: 19260742 DOI: 10.1043/1543-2165-133.3.365] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
385 Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med. 2009;133:365-374. [PMID: 19260742 DOI: 10.5858/133.3.365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 85] [Article Influence: 1.3] [Reference Citation Analysis]
386 Zech CJ, Bruns C, Reiser MF, Herrmann KA. [Tumor-like lesion of the pancreas in chronic pancreatitis : imaging characteristics of computed tomography]. Radiologe 2008;48:777-84. [PMID: 18604517 DOI: 10.1007/s00117-008-1670-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
387 Pedrazzoli S, Pasquali C, Guzzinati S, Berselli M, Sperti C. Survival rates and cause of death in 174 patients with chronic pancreatitis. J Gastrointest Surg. 2008;12:1930-1937. [PMID: 18766421 DOI: 10.1007/s11605-008-0620-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
388 Ardengh JC, Coelho N, Osvaldt AB. [Early pancreatic cancer: can the methods currently available identify this disease?]. Arq Gastroenterol 2008;45:169-77. [PMID: 18622475 DOI: 10.1590/s0004-28032008000200016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
389 Marrache F, Tu SP, Bhagat G, Pendyala S, Osterreicher CH, Gordon S, Ramanathan V, Penz-Osterreicher M, Betz KS, Song Z. Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology. 2008;135:1277-1287. [PMID: 18789941 DOI: 10.1053/j.gastro.2008.06.078] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
390 Leder G, Formentini A, Hoffmann M, Henne-Bruns D. [Rare cause of recurring necrotising pancreatitis]. Chirurg 2008;79:252-7. [PMID: 17879072 DOI: 10.1007/s00104-007-1415-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 Gachago C, Draganov PV. Pain management in chronic pancreatitis. World J Gastroenterol 2008; 14(20): 3137-3148 [PMID: 18506917 DOI: 10.3748/wjg.14.3137] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
392 Beger HG, Rau B, Gansauge F, Leder G, Schwarz M, Poch B. Pancreatic cancer--low survival rates. Dtsch Arztebl Int. 2008;105:255-262. [PMID: 19629206 DOI: 10.3238/arztebl.2008.0255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.2] [Reference Citation Analysis]
393 Mukherjee R, Criddle DN, Gukovskaya A, Pandol S, Petersen OH, Sutton R. Mitochondrial injury in pancreatitis. Cell Calcium. 2008;44:14-23. [PMID: 18207570 DOI: 10.1016/j.ceca.2007.11.013] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
394 Nakamura T, Kuwai T, Kim JS, Fan D, Kim SJ, Fidler IJ. Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice. Neoplasia 2007;9:979-86. [PMID: 18030366 DOI: 10.1593/neo.07742] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
395 Novak I. Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signal 2008;4:237-53. [PMID: 18368520 DOI: 10.1007/s11302-007-9087-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
396 Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 2007;102:2696-707. [PMID: 17764494 DOI: 10.1111/j.1572-0241.2007.01510.x] [Cited by in Crossref: 226] [Cited by in F6Publishing: 198] [Article Influence: 15.1] [Reference Citation Analysis]
397 Greer JB, Whitcomb DC, Brand RE. Genetic predisposition to pancreatic cancer: a brief review. Am J Gastroenterol 2007;102:2564-9. [PMID: 17958761 DOI: 10.1111/j.1572-0241.2007.01475.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
398 Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI; Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460-9. [PMID: 17872573 DOI: 10.1136/gut.2006.108456] [Cited by in Crossref: 208] [Cited by in F6Publishing: 192] [Article Influence: 13.9] [Reference Citation Analysis]
399 Church NI, Pereira SP, Churchill D, Cairns S, Hatfield AR, Webster GJ. Chronic pancreatitis: diagnosis and management of complications. Gut 2007;56:1189-90. [PMID: 17698865 DOI: 10.1136/gut.2007.132498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
400 Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol 2007;34:303-10. [PMID: 17674958 DOI: 10.1053/j.seminoncol.2007.05.003] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
401 Chari ST. Detecting early pancreatic cancer: problems and prospects. Semin Oncol. 2007;34:284-294. [PMID: 17674956 DOI: 10.1053/j.seminoncol.2007.05.005] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
402 Hu R, Wang YL, Edderkaoui M, Lugea A, Apte MV, Pandol SJ. Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology. 2007;7:332-340. [PMID: 17627098 DOI: 10.1159/000105499] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
403 Mayerle J, Lerch MM. Is it necessary to distinguish between alcoholic and nonalcoholic chronic pancreatitis? J Gastroenterol. 2007;42 Suppl 17:127-130. [PMID: 17238041 DOI: 10.1007/s00535-006-1920-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
404 Schima W, Ba-Ssalamah A, Plank C, Kulinna-Cosentini C, Püspök A. [Pancreas. Part I: congenital changes, acute and chronic pancreatitis]. Radiologe 2006;46:321-35; quiz 336. [PMID: 16496105 DOI: 10.1007/s00117-006-1340-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
405 Cruz-Monserrate Z, Qiu S, Evers BM, O’Connor KL. Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod Pathol. 2007;20:656-667. [PMID: 17415382 DOI: 10.1038/modpathol.3800782] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
406 Finkel HE. Wine and health: a review and perspective. Journal of Wine Research 1996;7:157-96. [DOI: 10.1080/09571269608718081] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
407 Omary MB, Lugea A, Lowe AW, Pandol SJ. The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest 2007;117:50-9. [PMID: 17200706 DOI: 10.1172/JCI30082] [Cited by in Crossref: 422] [Cited by in F6Publishing: 451] [Article Influence: 28.1] [Reference Citation Analysis]
408 Su Y, Büchler P, Gazdhar A, Giese N, Reber HA, Hines OJ, Giese T, Büchler MW, Friess H. Pancreatic regeneration in chronic pancreatitis requires activation of the notch signaling pathway. J Gastrointest Surg 2006;10:1230-41; discussion 1242. [PMID: 17114010 DOI: 10.1016/j.gassur.2006.08.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
409 Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: Diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 2007; 13(6): 858-865 [PMID: 17352014 DOI: 10.3748/wjg.v13.i6.858] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
410 Schima W, Ba-Ssalamah A, Plank C, Kulinna-Cosentini C, Prokesch R, Tribl B, Sautner T, Niederle B. [Pancreas. Part II: Tumors]. Radiologe 2006;46:421-37; quiz 438. [PMID: 16715226 DOI: 10.1007/s00117-006-1372-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
411 Kamisawa T. Is there a causal relation between pancreas divisum and pancreatic cancer? J Gastroenterol 2006;41:1131-2. [PMID: 17160527 DOI: 10.1007/s00535-006-1964-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
412 Schima W, Ba-Ssalamah A, Kölblinger C, Kulinna-Cosentini C, Puespoek A, Götzinger P. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638-649. [PMID: 17021700 DOI: 10.1007/s00330-006-0435-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 6.1] [Reference Citation Analysis]
413 Yu J, Ohuchida K, Mizumoto K, Ishikawa N, Ogura Y, Yamada D, Egami T, Fujita H, Ohashi S, Nagai E, Tanaka M. Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer. World J Gastroenterol 2006; 12(24): 3878-3882 [PMID: 16804974 DOI: 10.3748/wjg.v12.i24.3878] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
414 Nilsson HO, Stenram U, Ihse I, Wadström T. Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol 2006; 12(19): 3038-3043 [PMID: 16718784 DOI: 10.3748/wjg.v12.i19.3038] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
415 Kriegel AM, Soliman AS, Zhang Q, El-Ghawalby N, Ezzat F, Soultan A, Abdel-Wahab M, Fathy O, Ebidi G, Bassiouni N, Hamilton SR, Abbruzzese JL, Lacey MR, Blake DA. Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt. Environ Health Perspect 2006;114:113-9. [PMID: 16393667 DOI: 10.1289/ehp.8035] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
416 Juuti A, Louhimo J, Nordling S, Ristimäki A, Haglund C. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol. 2006;59:382-386. [PMID: 16467169 DOI: 10.1136/jcp.2005.026831] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
417 Malfertheiner P, Schütte K. Smoking--a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 2006;101:160-2. [PMID: 16405549 DOI: 10.1111/j.1572-0241.2006.00402.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
418 Jeong S, Lee DH, Lee JI, Lee JW, Kwon KS, Kim PS, Kim HG, Shin YW, Kim YS, Kim YB. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J Gastroenterol 2005; 11(43): 6765-6769 [PMID: 16425381 DOI: 10.3748/wjg.v11.i43.6765] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
419 McWilliams R, Highsmith WE, Rabe KG, de Andrade M, Tordsen LA, Holtegaard LM, Petersen GM. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 2005;54:1661-2. [PMID: 16227367 DOI: 10.1136/gut.2005.074534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
420 Askari MD, Tsao MS, Schuller HM. The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol. 2005;131:639-648. [PMID: 16091975 DOI: 10.1007/s00432-005-0002-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 3.6] [Reference Citation Analysis]
421 Lüttges J, Klöppel G. [Pancreatic ductal adenocarcinoma and its precursors]. Pathologe 2005;26:12-7. [PMID: 15630571 DOI: 10.1007/s00292-004-0735-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
422 Lowenfels AB, Sullivan T, Fiorianti J, Maisonneuve P. The epidemiology and impact of pancreatic diseases in the United States. Curr Gastroenterol Rep. 2005;7:90-95. [PMID: 15802095 DOI: 10.1007/s11894-005-0045-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
423 Bell RH. Current surgical management of chronic pancreatitis. J Gastrointest Surg. 2005;9:144-154. [PMID: 15623456 DOI: 10.1016/j.gassur.2004.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
424 Pancreatric Section, British Society of Gastroenterology., Pancreatic Society of Great Britain and Ireland., Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., Royal College of Pathologists., Special Interest Group for Gastro-Intestinal Radiology. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 2005;54 Suppl 5:v1-16. [PMID: 15888770 DOI: 10.1136/gut.2004.057059] [Cited by in Crossref: 119] [Cited by in F6Publishing: 101] [Article Influence: 7.0] [Reference Citation Analysis]
425 Maisonneuve P, Lowenfels AB, Müllhaupt B, Cavallini G, Lankisch PG, Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L, Frulloni L, Ammann RW. Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 2005;54:510-4. [PMID: 15753536 DOI: 10.1136/gut.2004.039263] [Cited by in Crossref: 222] [Cited by in F6Publishing: 197] [Article Influence: 13.1] [Reference Citation Analysis]
426 Teich N, Keim V, Mössner J. [Clinical implications of genetic risk factors of chronic pancreatitis]. Internist (Berl) 2005;46:123-30. [PMID: 15655684 DOI: 10.1007/s00108-004-1320-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
427 van Kouwen MC, Jansen JB, van Goor H, de Castro S, Oyen WJ, Drenth JP. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging. 2005;32:399-404. [PMID: 15549297 DOI: 10.1007/s00259-004-1689-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
428 Nyska A, Jokinen MP, Brix AE, Sells DM, Wyde ME, Orzech D, Haseman JK, Flake G, Walker NJ. Exocrine pancreatic pathology in female Harlan Sprague-Dawley rats after chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds. Environ Health Perspect 2004;112:903-9. [PMID: 15175180 DOI: 10.1289/ehp.6869] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
429 Farrow B, Sugiyama Y, Chen A, Uffort E, Nealon W, Mark Evers B. Inflammatory mechanisms contributing to pancreatic cancer development. Ann Surg. 2004;239:763-779; discussion 763-779;. [PMID: 15166955 DOI: 10.1097/01.sla.0000128681.76786.07] [Cited by in Crossref: 114] [Cited by in F6Publishing: 104] [Article Influence: 6.3] [Reference Citation Analysis]
430 Boll DT, Merkle EM. Differentiating a chronic hyperplastic mass from pancreatic cancer: a challenge remaining in multidetector CT of the pancreas. Eur Radiol 2003;13 Suppl 5:M42-9. [PMID: 14989611 DOI: 10.1007/s00330-003-2100-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
431 Rodriguez Rilo HL, Ahmad SA, D’Alessio D, Iwanaga Y, Kim J, Choe KA, Moulton JS, Martin J, Pennington LJ, Soldano DA. Total pancreatectomy and autologous islet cell transplantation as a means to treat severe chronic pancreatitis. J Gastrointest Surg. 2003;7:978-989. [PMID: 14675707 DOI: 10.1016/j.gassur.2003.09.008] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 5.6] [Reference Citation Analysis]
432 Ren YX, Xu GM, Li ZS, Song YG. Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J Gastroenterol 2004; 10(6): 881-884 [PMID: 15040037 DOI: 10.3748/wjg.v10.i6.881] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
433 Ren YX, Xu GM, Li ZS, Liu F. Aberrant expression and mutations of K-ras gene in pancreatic adenocarcinoma and chronic pancreatitis. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 664-668 [DOI: 10.11569/wcjd.v12.i3.664] [Reference Citation Analysis]
434 Barman KK, Premalatha G, Mohan V. Tropical chronic pancreatitis. Postgrad Med J. 2003;79:606-615. [PMID: 14654569 DOI: 10.1136/pmj.79.937.606] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
435 Mu DQ, Peng YS, Xu QJ. Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience. World J Gastroenterol 2004; 10(4): 471-475 [PMID: 14966900 DOI: 10.3748/wjg.v10.i4.471] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
436 Lynch HT, Deters CA, Lynch JF, Brand RE. Familial pancreatic carcinoma in Jews. Familial Cancer 2004;3:233-40. [DOI: 10.1007/s10689-004-9549-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
437 Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World J Surg 2003;27:1249-57. [PMID: 14502404 DOI: 10.1007/s00268-003-7245-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.5] [Reference Citation Analysis]
438 Mu DQ, Wang GF, Peng SY. p53 protein expression and CA19.9 values in differential cytological diagnosis of pancreatic cancer complicated with chronic pancreatitis and chronic pancreatitis. World J Gastroenterol 2003; 9(8): 1815-1818 [PMID: 12918127 DOI: 10.3748/wjg.v9.i8.1815] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
439 Hartel M, Tempia-Caliera AA, Wente MN, Z'graggen K, Friess H, Büchler MW. Evidence-based surgery in chronic pancreatitis. Langenbecks Arch Surg 2003;388:132-9. [PMID: 12712343 DOI: 10.1007/s00423-003-0361-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
440 Foster, Md, Phd, Dsc, Frcpath CS, Dodson A, Neoptolemos, Ma, Md, Frcs JP, Cornford, Frcs PA, Evans, Md, Frcs JD. Expression Patterns of Protein Kinase C Isoenzymes Are Characteristically Modulated in Chronic Pancreatitis and Pancreatic Cancer. American Journal of Clinical Pathology 2003;119:0-0. [DOI: 10.1309/bkpc-9dx9-8r78-1b87] [Reference Citation Analysis]
441 Charnley RM. Hereditary pancreatitis. World J Gastroenterol 2003; 9(1): 1-4 [PMID: 12508340 DOI: 10.3748/wjg.v9.i1.1] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
442 Howes N, Neoptolemos JP. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut 2002;51:765-6. [PMID: 12427771 DOI: 10.1136/gut.51.6.765] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
443 Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, Lévy P, Ruszniewski P. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002;51:849-52. [PMID: 12427788 DOI: 10.1136/gut.51.6.849] [Cited by in Crossref: 298] [Cited by in F6Publishing: 259] [Article Influence: 14.9] [Reference Citation Analysis]
444 Fritscher-Ravens A, Brand L, Knöfel WT, Bobrowski C, Topalidis T, Thonke F, de Werth A, Soehendra N. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol 2002;97:2768-75. [PMID: 12425546 DOI: 10.1111/j.1572-0241.2002.07020.x] [Cited by in Crossref: 194] [Cited by in F6Publishing: 155] [Article Influence: 9.7] [Reference Citation Analysis]
445 Maire F, Micard S, Hammel P, Voitot H, Lévy P, Cugnenc PH, Ruszniewski P, Puig PL. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br J Cancer 2002;87:551-4. [PMID: 12189555 DOI: 10.1038/sj.bjc.6600475] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 4.6] [Reference Citation Analysis]
446 Ye W, Lagergren J, Weiderpass E, Nyrén O, Adami HO, Ekbom A. Alcohol abuse and the risk of pancreatic cancer. Gut 2002;51:236-9. [PMID: 12117886 DOI: 10.1136/gut.51.2.236] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
447 Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest. 2002;109:1437-1444. [PMID: 12045257 DOI: 10.1172/jci0215051] [Cited by in Crossref: 139] [Cited by in F6Publishing: 71] [Article Influence: 7.0] [Reference Citation Analysis]
448 Crawford HC, Scoggins CR, Washington MK, Matrisian LM, Leach SD. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002;109:1437-44. [PMID: 12045257 DOI: 10.1172/JCI15051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 88] [Article Influence: 0.1] [Reference Citation Analysis]
449 Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002;160:1573-81. [PMID: 12000709 DOI: 10.1016/S0002-9440(10)61104-2] [Cited by in Crossref: 143] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
450 Magee CJ, Shekouh A, Ghaneh P, Neoptolemos JP. Update on pancreatic cancer. Hosp Med 2002;63:200-6. [PMID: 11995268 DOI: 10.12968/hosp.2002.63.4.2036] [Reference Citation Analysis]
451 Whitcomb DC. How to think about SPINK and pancreatitis. Am J Gastroenterol 2002;97:1085-8. [PMID: 12014708 DOI: 10.1111/j.1572-0241.2002.05697.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
452 Schernhammer ES, Michaud DS, Leitzmann MF, Giovannucci E, Colditz GA, Fuchs CS. Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer. 2002;86:1081-1084. [PMID: 11953853 DOI: 10.1038/sj.bjc.6600193] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
453 Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J, Büchler MW. Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001;234:769-78; discussion 778-9. [PMID: 11729383 DOI: 10.1097/00000658-200112000-00008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
454 Pukkala E, Pönkä A. Increased incidence of cancer and asthma in houses built on a former dump area. Environ Health Perspect 2001;109:1121-5. [PMID: 11712996 DOI: 10.1289/ehp.011091121] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
455 Ye W, Lagergren J, Nyrén O, Ekbom A. Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden. Gut 2001;49:678-81. [PMID: 11600471 DOI: 10.1136/gut.49.5.678] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
456 Gansauge F, Gansauge S, Eh M, Schlosser W, Ramadani M, Kern P, Beger HG. Distributional and functional alterations of immunocompetent peripheral blood lymphocytes in patients with chronic pancreatitis. Ann Surg 2001;233:365-70. [PMID: 11224624 DOI: 10.1097/00000658-200103000-00010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
457 Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 2001;153:680-7. [PMID: 11282796 DOI: 10.1093/aje/153.7.680] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 4.2] [Reference Citation Analysis]
458 Queneau PE, Adessi GL, Thibault P, Cléau D, Heyd B, Mantion G, Carayon P. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol 2001;96:700-4. [PMID: 11280537 DOI: 10.1111/j.1572-0241.2001.03608.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 1.3] [Reference Citation Analysis]
459 Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR, Brentnall TA. Inherited predisposition to pancreatic cancer. Gut 2001;48:143-7. [PMID: 11156628 DOI: 10.1136/gut.48.2.143] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
460 Howes N, Greenhalf W, Rutherford S, O'Donnell M, Mountford R, Ellis I, Whitcomb D, Imrie C, Drumm B, Neoptolemos JP. A new polymorphism for the RI22H mutation in hereditary pancreatitis. Gut 2001;48:247-50. [PMID: 11156648 DOI: 10.1136/gut.48.2.247] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
461 Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001;48:70-4. [PMID: 11115825 DOI: 10.1136/gut.48.1.70] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 4.2] [Reference Citation Analysis]
462 Löhr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol 2000;27:93-103. [PMID: 10862508 DOI: 10.1385/IJGC:27:2:093] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
463 Sakorafas GH, Farnell MB, Farley DR, Rowland CM, Sarr MG. Long-term results after surgery for chronic pancreatitis. Int J Pancreatol. 2000;27:131-142. [PMID: 10862512 DOI: 10.1385/IJGC:27:2:131] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
464 Heinmöller E, Dietmaier W, Zirngibl H, Heinmöller P, Scaringe W, Jauch KW, Hofstädter F, Rüschoff J. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 2000;157:83-92. [PMID: 10880379 DOI: 10.1016/S0002-9440(10)64520-8] [Cited by in Crossref: 75] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
465 Abe H, Kimura W, Maema A, Makuuchi M. A case of pancreatic carcinoma with marked ductal dilatation: what contributed to the dilatation? Int J Pancreatol 2000;27:65-8. [PMID: 10811025 DOI: 10.1385/IJGC:27:1:65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
466 Soler M, Malats N, Porta M, Fernandez E, Guarner L, Maguire A, Pinõl JL, Rifà J, Carrato A. Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group. Dig Dis Sci 1999;44:2469-77. [PMID: 10630499 DOI: 10.1023/a:1026635005363] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 0.8] [Reference Citation Analysis]
467 Hart AR. Pancreatic cancer: any prospects for prevention? Postgrad Med J 1999;75:521-6. [PMID: 10616684 DOI: 10.1136/pgmj.75.887.521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
468 Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000;95:17-31. [PMID: 10638554 DOI: 10.1111/j.1572-0241.2000.01699.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 5.1] [Reference Citation Analysis]
469 Beger HG, Schlosser W, Friess HM, Büchler MW. Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience. Ann Surg. 1999;230:512-519; discussion 512-519. [PMID: 10522721 DOI: 10.1097/00000658-199910000-00007] [Cited by in Crossref: 188] [Cited by in F6Publishing: 129] [Article Influence: 8.2] [Reference Citation Analysis]
470 Talamini G, Bassi C, Falconi M, Sartori N, Pasetto M, Salvia R, Di Francesco V, Frulloni L, Vaona B, Bovo P, Pederzoli P, Cavallini G. Early detection of pancreatic cancer following the diagnosis of chronic pancreatitis. Digestion 1999;60:554-61. [PMID: 10545726 DOI: 10.1159/000007706] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
471 Talamini G, Bassi C, Falconi M, Sartori N, Salvia R, Rigo L, Castagnini A, Di Francesco V, Frulloni L, Bovo P. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44:1303-1311. [PMID: 10489910 DOI: 10.1023/a: 1026670911955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
472 Talamini G, Bassi C, Falconi M, Sartori N, Salvia R, Rigo L, Castagnini A, Di Francesco V, Frulloni L, Bovo P. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci. 1999;44:1303-1311. [PMID: 10489910 DOI: 10.1023/a:1026670911955] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 7.2] [Reference Citation Analysis]
473 Bramhall SR. The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis. Int J Pancreatol 1998;23:83-100. [PMID: 9629506 DOI: 10.1385/IJGC:23:2:83] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
474 Ebert M, Kasper HU, Hernberg S, Friess H, Büchler MW, Roessner A, Korc M, Malfertheiner P. Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci. 1998;43:567-574. [PMID: 9539653 DOI: 10.1023/a:1018867209170] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
475 Reubi JC, Waser B, Friess H, Büchler M, Laissue J. Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma. Gut 1998;42:546-50. [PMID: 9616318 DOI: 10.1136/gut.42.4.546] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 5.5] [Reference Citation Analysis]
476 Yamaguchi K, Nakamura K, Yokohata K, Shimizu S, Chijiiwa K, Tanaka M. Pancreatic cyst as a sentinel of in situ carcinoma of the pancreas. Report of two cases. Int J Pancreatol. 1997;22:227-231. [PMID: 9444555 DOI: 10.1007/bf02788389] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
477 Evans JD, Morton DG, Neoptolemos JP. Chronic pancreatitis and pancreatic carcinoma. Postgrad Med J. 1997;73:543-548. [PMID: 9373592 DOI: 10.1136/pgmj.73.863.543] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
478 Wharton SM, Rahman Z, Johnson CD. Missed curable carcinoma of the pancreas presenting as chronic pancreatitis. Postgrad Med J 1997;73:577-9. [PMID: 9373601 DOI: 10.1136/pgmj.73.863.577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
479 Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S, Waldman SA. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest. 1997;100:597-603. [PMID: 9239407 DOI: 10.1172/JCI119570] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 2.8] [Reference Citation Analysis]
480 Maacke H, Kessler A, Schmiegel W, Roeder C, Vogel I, Deppert W, Kalthoff H. Overexpression of p53 protein during pancreatitis. Br J Cancer. 1997;75:1501-1504. [PMID: 9166944 DOI: 10.1038/bjc.1997.256] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
481 Yamaguchi K, Chijiiwa K, Saiki S, Nakatsuka A, Tanaka M. "Mass-forming" pancreatitis masquerades as pancreatic carcinoma. Int J Pancreatol 1996;20:27-35. [PMID: 8872521 DOI: 10.1007/BF02787373] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
482 Sidhu S, Tandon RK. Chronic pancreatitis: diagnosis and treatment. Postgrad Med J 1996;72:327-33. [PMID: 8758008 DOI: 10.1136/pgmj.72.848.327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
483 Hansen TH, Laursen M, Christensen E, Worning H. Chronic pancreatitis and extrapancreatic cancer: a retrospective study among 181 patients with chronic pancreatitis. Int J Pancreatol 1995;18:235-9. [PMID: 8708395 DOI: 10.1007/BF02784947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
484 Van Gossum A, Closset P, Noel E, Cremer M, Neve J. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Dig Dis Sci. 1996;41:1225-1231. [PMID: 8654156 DOI: 10.1016/0016-5085(95)24246-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
485 Schmielau J, Kalthoff H, Roeder C, Schmiegel W. The role of cytokines in pancreatic cancer. Int J Pancreatol 1996;19:157-63. [PMID: 8807360 DOI: 10.1007/BF02787363] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
486 Rutishauser SC, Ali AE, Jeffrey IJ, Hunt LP, Braganza JM. Toward an animal model of chronic pancreatitis. Pancreatobiliary secretion in hamsters on long-term treatment with chemical inducers of cytochromes P450. Int J Pancreatol 1995;18:117-26. [PMID: 8530827 DOI: 10.1007/BF02785885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
487 Evans JP, Burke W, Chen R, Bennett RL, Schmidt RA, Dellinger EP, Kimmey M, Crispin D, Brentnall TA, Byrd DR. Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 1995;32:330-5. [PMID: 7616537 DOI: 10.1136/jmg.32.5.330] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
488 Van Laethem JL, Vertongen P, Deviere J, Van Rampelbergh J, Rickaert F, Cremer M, Robberecht P. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut 1995;36:781-7. [PMID: 7797131 DOI: 10.1136/gut.36.5.781] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 2.6] [Reference Citation Analysis]
489 Cowles SR, Tsai SP, Gilstrap EL, Ross CE. Mortality among employees at a plastics and resins research and development facility. Occup Environ Med. 1994;51:799-803. [PMID: 7849862 DOI: 10.1136/oem.51.12.799] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
490 Nakamura R, Machado R, Amikura K, Ruebner B, Frey CF. Role of fine needle aspiration cytology and endoscopic biopsy in the preoperative assessment of pancreatic and peripancreatic malignancies. Int J Pancreatol 1994;16:17-21. [PMID: 7806910 DOI: 10.1007/BF02925605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
491 Korc M, Friess H, Yamanaka Y, Kobrin MS, Buchler M, Beger HG. Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gamma. Gut 1994;35:1468-73. [PMID: 7959207 DOI: 10.1136/gut.35.10.1468] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
492 Trümper LH, Bürger B, von Bonin F, Hintze A, von Blohn G, Pfreundschuh M, Daus H. Diagnosis of pancreatic adenocarcinoma by polymerase chain reaction from pancreatic secretions. Br J Cancer 1994;70:278-84. [PMID: 8054276 DOI: 10.1038/bjc.1994.292] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
493 Friess H, Yamanaka Y, Büchler M, Hammer K, Kobrin MS, Beger HG, Korc M. A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann Surg 1994;220:183-92. [PMID: 7519839 DOI: 10.1097/00000658-199408000-00010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
494 Ekbom A, McLaughlin JK, Nyrén O. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 1993;329:1502-3. [PMID: 8413467 DOI: 10.1056/NEJM199311113292016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]